https://www.pharmaradar360.com hourly 1 https://www.pharmaradar360.com/news hourly 0.95 https://www.pharmaradar360.com/regulators daily 0.9 https://www.pharmaradar360.com/trials daily 0.85 https://www.pharmaradar360.com/pipeline daily 0.9 https://www.pharmaradar360.com/drug-approvals daily 0.9 https://www.pharmaradar360.com/journals weekly 0.8 https://www.pharmaradar360.com/pharma-companies weekly 0.8 https://www.pharmaradar360.com/specialties weekly 0.8 https://www.pharmaradar360.com/sources weekly 0.8 https://www.pharmaradar360.com/newsrooms weekly 0.8 https://www.pharmaradar360.com/pharma-tools weekly 0.8 https://www.pharmaradar360.com/pharma-communities weekly 0.75 https://www.pharmaradar360.com/pro weekly 0.75 https://www.pharmaradar360.com/tools weekly 0.7 https://www.pharmaradar360.com/about monthly 0.5 https://www.pharmaradar360.com/privacy yearly 0.35 https://www.pharmaradar360.com/support monthly 0.35 https://www.pharmaradar360.com/disclaimer yearly 0.35 https://www.pharmaradar360.com/drug/pembrolizumab daily 0.9 https://www.pharmaradar360.com/drug/semaglutide daily 0.9 https://www.pharmaradar360.com/drug/tirzepatide daily 0.9 https://www.pharmaradar360.com/drug/trastuzumab-deruxtecan daily 0.9 https://www.pharmaradar360.com/drug/osimertinib daily 0.9 https://www.pharmaradar360.com/drug/nivolumab daily 0.9 https://www.pharmaradar360.com/drug/dupilumab daily 0.9 https://www.pharmaradar360.com/drug/risankizumab daily 0.9 https://www.pharmaradar360.com/drug/lecanemab daily 0.9 https://www.pharmaradar360.com/drug/atezolizumab daily 0.9 https://www.pharmaradar360.com/article/must-see-museums-the-heritage-gallery-f8ae478aab63fcf2 2026-09-15T16:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/minnesota-healthcare-providers-detail-harm-to-patients-from-operation-metro-surg-1431dfd58da5f22f 2026-09-15T16:34:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/minnesota-private-well-owners-are-largely-on-their-own-when-it-comes-to-arsenic-592a54313504782c 2026-09-15T16:33:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-a-federal-mail-in-ballot-proposal-means-for-minnesota-voters-37e175b0fe4b7083 2026-09-15T16:33:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/planning-to-repair-your-lawn-this-fall-here-s-what-you-need-to-know-7863c5bdc59effd1 2026-09-15T16:32:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/jd-vance-s-catholicism-could-be-at-odds-with-maga-evangelicals-in-2028-92a05500444ddfe5 2026-09-15T16:31:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-energy-uc-irvine-never-used-47d02add849c9ba3 2026-09-15T16:21:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/ich-kann-zeigen-was-ich-kann-schon-in-jungem-alter-bd19b1665f8d76d6 2026-09-15T16:04:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-queueing-science-could-fix-hub-staffing-guesswork-8b1c0f65b7491859 2026-09-15T16:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/official-statistics-quarterly-reports-on-the-import-of-unlicensed-medicines-ad6b052d146f111a 2026-09-15T15:57:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/waltham-biotech-cuts-nearly-half-its-workforce-after-cystic-fibrosis-drug-fails-154605cf755a25bf 2026-09-15T15:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-signs-10-year-120m-deal-to-automate-commercial-cell-therapy-manufact-adbe486e7d89146b 2026-09-15T15:52:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/guy-s-pharmacy-launches-medicine-collection-lockers-81967b05e661e7b2 2026-09-15T15:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenio-de-colaboracion-con-la-defensoria-de-la-ninez-bee014f00dc8db5c 2026-09-15T15:38:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-estudiante-que-representara-al-pais-en-un-congreso-aeroespacial-visito-el-rec-6eb1e2fe926ccbe3 2026-09-15T15:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/constituimos-la-mesa-de-computacion-cuantica-89b47da77220d081 2026-09-15T15:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-entrepreneur-philip-goelet-joins-whitehead-institute-board-of-directors-73e5ecc85fa4e229 2026-09-15T15:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-researchers-awarded-1m-wall-fellowships-to-advance-human-and-ecosystem-healt-44c569f2963ac6a1 2026-09-15T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/material-de-lectura-8517301ac515699d 2026-09-15T15:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/concursos-nodocentes-983118a1cfff9744 2026-09-15T15:28:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/concursos-presidencia-0738a9ef10c73b04 2026-09-15T15:28:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-micro-de-la-maternite-un-podcast-pour-s-informer-sur-sa-grossesse-53d9972b3d11bf70 2026-09-15T15:19:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-partnership-creates-pathway-from-clarkson-college-to-unmc-pharmacy-programs-fbb78b823002db73 2026-09-15T15:08:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-curi-bio-s-letter-of-intent-into-istand-program-to-qualify-3d-neurom-00b00f0510c84820 2026-09-15T15:06:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/smelling-chocolate-helped-men-complete-more-reps-without-feeling-more-tired-d83c990ebb92dc03 2026-09-15T15:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-a-playbook-for-dscsa-value-beyond-compliance-eb0d87a1e73b22ed 2026-09-15T15:02:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-2e56b8e582b343fa 2026-09-15T14:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-75f7dce44dd8df60 2026-09-15T14:58:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-advisory-panel-ukap-enquiry-form-38f5d243521e9931 2026-09-15T14:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/imvax-announces-additional-data-from-phase-2b-clinical-trial-of-igv-001-in-newly-d5d0f8a72497251b 2026-09-15T14:48:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-industry-wrote-montana-s-right-to-try-law-now-they-re-running-the-sh-d462381332cb2633 2026-09-15T14:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-entrepreneurs-vie-for-35k-shark-tank-style-f9820b04c2555df4 2026-09-15T14:41:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-primary-children-s-hospitals-once-again-ranked-among-nation-002824e58ab7f154 2026-09-15T14:41:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-raises-33m-for-cancer-drug-development-73485c033219a385 2026-09-15T14:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-driven-envirolab-team-maps-the-heat-06daa6d460a43865 2026-09-15T14:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hears-80-speakers-on-psychedelic-drug-therapy-standards-08469c1399c0a84a 2026-09-15T14:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-a-major-brain-shift-between-ages-50-and-75-aa4a9d132a2808ca 2026-09-15T14:28:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-4f7584c7886f13aa 2026-09-15T14:27:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-ai-trust-gap-slowing-healthcare-provider-adoption-survey-reveals-c9537e83af37e3d8 2026-09-15T14:24:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-to-acquire-potential-best-in-class-t-cell-engager-tce-for-multiple-myeloma-f-62e7d22436b47e77 2026-09-15T14:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/supporting-complex-phase-i-studies-through-integrated-imaging-and-specialized-as-0e0c38380763ff9c 2026-09-15T14:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/defining-ad-disease-flares-vs-drug-effects-a-comparative-analysis-of-phase-3-sys-9b3a6140d8d68e9f 2026-09-15T14:14:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/stakeholders-urge-fda-to-define-data-treatment-standards-as-psychedelic-drugs-ne-f1bbb0b0fd948389 2026-09-15T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/connect-s-dupixent-rival-flunks-phase-2-asthma-trial-but-biotech-sees-reasons-fo-df8ae3f97c319dcf 2026-09-15T13:55:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-drugmakers-are-testing-in-kids-as-young-as-6-15423b2c677d102a 2026-09-15T13:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-new-drug-trial-approvals-at-cspc-pharmaceutical-group-stock-has-changed-its-286c1b7011894676 2026-09-15T13:50:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-oric-doubles-down-on-prostate-cancer-with-phase-3-launch-f66cc21c17ead25d 2026-09-15T13:47:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-11-october-2026-f8d136078761e069 2026-09-15T13:45:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-42-report-data-to-week-41-data-up-t-c191b99be464c1cd 2026-09-15T13:45:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-42-report-data-to-week-41-dat-81e64c216725e952 2026-09-15T13:45:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/encuentro-sobre-inmigracion-italiana-en-la-unlp-674fd69b0a715368 2026-09-15T13:44:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-61814d75375f6c45 2026-09-15T13:43:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positi-5456029ae019c373 2026-09-15T13:38:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-clarifies-post-marketing-requirements-for-isembyld-after-fda-approv-af85aacc1f2d7ef7 2026-09-15T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-announces-ceo-changes-22b3bb122bfb973d 2026-09-15T13:20:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-overlooked-science-of-ecoa-when-good-clinical-outcome-assessments-still-prod-a1cf5235c4a8deff 2026-09-15T13:19:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-320-pain-professionals-attended-ensysce-s-symposium-on-complex-pain-e8c78633cfca9b32 2026-09-15T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-plan-for-england-d59ff0423140ac07 2026-09-15T13:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-340b-rebate-tracking-really-demands-from-pharmacies-1036825346f0ecd9 2026-09-15T13:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-084ce903ab0026f7 2026-09-15T13:05:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-public-hearing-on-psychedelic-drug-therapies-sept-2026-bbfdc7e67a996d89 2026-09-15T13:02:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-can-focused-ultrasound-treat-tremor-and-movement-symptoms-in-parkinson-s-dis-7207a68b37946004 2026-09-15T13:02:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-names-novartis-executive-as-ceo-504f6ae79a3fda8f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/they-had-a-plan-how-sophia-s-parents-found-care-for-rohhad-syndrome-a0e028ec4c72bb5f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-covid-19-inquiry-53a03ab2ca904c16 2026-09-15T12:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-americans-really-want-from-drug-ads-2bb4904fef97820f 2026-09-15T12:52:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-group-announces-swissmedic-approval-of-cerbios-expanded-reduced-folates-prod-0e7a73cb46e0db15 2026-09-15T12:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/heilbronn-ai-virtual-networking-week-2026-dec5a1ccfcccd8e8 2026-09-15T12:48:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-2e29865224852ac9 2026-09-15T12:46:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-151b6723d1790a16 2026-09-15T12:42:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-creating-an-individual-data-return-template-a-patient-centered-approach-by-ci-8088f2b95ea81f5a 2026-09-15T12:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/heilbronn-ai-fellowship-becas-para-estancias-de-investigacion-en-inteligencia-ar-6d9a9023f63f4ac4 2026-09-15T12:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-raises-definium-therapeutics-price-target-on-trial-results-823ad11d724e1346 2026-09-15T12:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-la-noche-de-los-lapices-recuperar-la-historia-para-construir-nuevas-b16602b68dc469b8 2026-09-15T12:30:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-adults-with-multiple-or-complex-health-conditions-face-significant-challe-07e5b9e1d7bf6098 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-access-and-affordability-for-adults-with-multiple-or-complex-health-40f35f4aa2e21f66 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-8c59bede56b31042 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccination-of-people-with-uncertain-or-incomplete-immunisation-2614a700ef581637 2026-09-15T12:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/let-s-talk-with-sorrisi-in-rosa-10-anni-insieme-a936d1bccd7f37c2 2026-09-15T12:21:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-announces-insider-share-purchases-by-board-member-and-ceo-ami-5517cde72350edd4 2026-09-15T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-habilita-una-nueva-aplicacion-para-presentar-telematicamente-la-declara-ced439fd208ddf21 2026-09-15T12:09:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/compass-pathways-just-answered-the-durability-question-now-comes-the-harder-prob-91b82d6d78659f27 2026-09-15T12:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nkgen-biotech-to-present-on-troculeucel-for-75400b55930fb023 2026-09-15T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-a7a8016caf9792c3 2026-09-15T12:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/lenders-take-over-big-biotech-projects-from-developers-amid-weak-market-0da1139c9a272cf0 2026-09-15T12:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-legend-biotech-nasdaq-legn-ceo-could-get-10m-a-year-in-stock-grants-83bafaed24e453a0 2026-09-15T12:01:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ai-agents-invent-their-own-language-if-you-let-them-chat-9beb98df1bc5cd4b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organika-gummies-foreign-site-not-listed-on-site-licence-a84ecb8691e76e80 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-target-product-profile-where-clinical-development-meets-commercial-reality-49a27a3d5b010a47 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-appoints-ingrid-zhang-as-chief-executive-officer-1fc5f79e5180e8be 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-7332490dba27ec05 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-to-advance-scientific-dialogue-on-skin-longevity-aging-biolo-22d33810a0bd348b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/una-leona-en-el-rectorado-vicky-granatto-graduada-ilustre-de-la-unlp-0995f5cfd227b39d 2026-09-15T11:56:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-gets-breakthrough-therapy-designation-for-lung-cancer-drug-9a2411f77c5ff047 2026-09-15T11:50:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-formulation-development-solubility-enhancement-modified-release-and-a-50a246e993c73d45 2026-09-15T11:42:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-announces-topline-results-from-phase-2-address-lc-trial-evaluating-bezist-7ad61d619ea60776 2026-09-15T11:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/thirlwall-inquiry-report-e6a6b02f944b9e08 2026-09-15T11:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-doubles-down-on-china-biotech-paying-up-to-750-million-for-global-rights-to-7d22f9ea6a2666d5 2026-09-15T11:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-16-09-policlinico-kids-2-0-5666d4ba8d7e3d0f 2026-09-15T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-estimated-17-20-million-u-s-adults-live-with-long-covid-biovie-reports-benefi-eae313323506dbb4 2026-09-15T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/address-by-prof-mojisola-christianah-adeyeye-at-the-49th-annual-international-co-a2a7d60bb2244405 2026-09-15T11:23:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-bolsters-oncology-pipeline-with-750m-chimagen-tce-deal-826c82260bc41af2 2026-09-15T11:21:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-1b21a6d7086131d4 2026-09-15T11:16:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-10705eb8501f8596 2026-09-15T11:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-15d9a37158cd8455 2026-09-15T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-and-bioavailability-key-insights-from-quotient-sciences-at-cphi-milan-2026-pa-d647b90c22d390b2 2026-09-15T11:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/dompe-u-s-pays-32-million-to-resolve-co-pay-foundation-kickback-allegations-foll-a18a9b45edf7a74d 2026-09-15T11:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/sacking-football-managers-does-not-improve-performance-study-finds-03c01ac7a2e8e41e 2026-09-15T11:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-performed-in-the-microbiology-department-of-vall-d-hebron-university-hos-a8d24f15864f0602 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-df8feae142024a4b 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/debut-engineers-new-biotech-ingredient-for-hyperpigmentation-bd42adb0c0606c65 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-kidney-drug-trutakna-shows-strong-final-results-in-phase-3-trial-df6628efe3598540 2026-09-15T10:53:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/meiji-group-to-showcase-japanese-quality-cmo-cdmo-services-and-a-global-manufact-e52ed07ed40f30ac 2026-09-15T10:49:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-gum-disease-before-it-starts-with-ai-9fb6b31196acfe4a 2026-09-15T10:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-trustees-announced-as-cancer-research-uk-strengthens-research-and-governance-b0e6efe05865e793 2026-09-15T10:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-u-s-eradicated-this-flesh-eating-parasite-now-it-s-back-0a632145778feae0 2026-09-15T10:39:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-therapeutics-secures-strong-final-phase-3-data-for-kidney-drug-trutakna-36d5522ea33843a0 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-tulane-is-spotting-startup-gems-inside-stacks-of-academic-research-1f9769591bca433c 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-halts-early-stage-obesity-drug-development-d54510d85ed65bb4 2026-09-15T10:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/widow-s-bay-triumphs-as-most-decorated-freshman-comedy-in-emmy-history-73c1fed3e66c3e88 2026-09-15T10:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/veterans-and-doctors-urged-psychedelic-therapy-safety-standards-at-fda-hearing-w-fa6fb35f2fa9db3d 2026-09-15T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/preorder-dci-s-new-2026-27-economic-report-on-pharmaceutical-wholesalers-and-spe-cf342a4bd277e1b1 2026-09-15T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-radiology-abdomen-publishes-debut-articles-e0267cdf86aedfca 2026-09-15T09:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/florrax-pharmaceutical-updates-glp-core-tablet-product-information-in-dailymed-d-d44690b1b2608954 2026-09-15T09:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-new-nih-research-center-on-vaccine-harms-takes-shape-9fff0ee16aaaf112 2026-09-15T09:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-august-2026-1b10eeb5524e0803 2026-09-15T09:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/benemeat-warns-uk-eu-trade-deal-could-put-wider-biotech-ambitions-at-risk-fe6a683c0c2b29a5 2026-09-15T09:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-giving-the-biotech-industry-sweeping-authority-to-sell-unapproved-drug-2190e459be361d76 2026-09-15T09:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lorraine-hill-joins-industry-leaders-in-conversation-on-gender-leadership-and-th-7d42b07921023b67 2026-09-15T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wclc-lung-cancer-news-from-biontech-akeso-and-roche-40c82f5f181ab638 2026-09-15T09:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-fda-and-ema-now-accept-from-real-world-data-240492ab4fd2c3b1 2026-09-15T09:17:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/chief-medical-officer-of-precision-for-medicine-line-between-phase-1-and-2-trial-5f656497ea653dbf 2026-09-15T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connecting-data-people-and-patients-how-ai-is-advancing-neuroscience-clinical-tr-fbb7dc892cca538a 2026-09-15T09:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/century-adds-biotech-veteran-as-cell-therapies-near-milestones-1287adafcb6350ae 2026-09-15T09:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-get-caught-out-by-flu-this-winter-as-nhsggc-expands-vaccine-clinics-237642de4684a825 2026-09-15T09:08:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-1-is-ai-in-biotech-real-growth-or-hype-24ea2945d48f00f2 2026-09-15T09:05:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-regulation-and-the-dynamic-nature-of-ai-0c1651051d68903b 2026-09-15T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/las-enfermedades-cardiovasculares-superan-al-cancer-y-se-posicionan-como-causa-p-63d69fa22573e6ca 2026-09-15T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiovascular-disease-tops-cancer-as-leading-cause-of-death-among-hispanic-adul-8f0dc26cd592f4b7 2026-09-15T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-driving-simcere-pharmaceutical-group-sehk-2096-higher-today-38c1d46a98971355 2026-09-15T08:56:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-biotech-ai-trade-finds-real-fuel-e3b1dea7cc9273dc 2026-09-15T08:56:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-15-september-2026-a7c5aa202e8d1a2b 2026-09-15T08:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanyang-precision-chairman-faces-breach-of-trust-embezzlement-allegations-7630c5cc0a515910 2026-09-15T08:51:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/qasim-treated-by-specialists-with-all-the-rare-blood-available-across-the-countr-cf8bbd18e6915c1a 2026-09-15T08:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/bloodborne-virus-testing-in-prisons-and-other-places-of-detention-19658f88bc805354 2026-09-15T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/leprosy-notifications-to-uk-national-surveillance-2001-to-2025-cbea52de19821e05 2026-09-15T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fratture-costali-nuove-frontiere-chirurgiche-mininvasive-al-policlinico-di-milan-ae965af1975ddb4c 2026-09-15T08:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-interest-in-chugai-pharmaceutical-co-ltd-unsponsored-adr-otcmkts-chgcy-exp-0ad45629e5c18f34 2026-09-15T08:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-science-unpicking-data-diversity-and-inclusive-research-design-e2ec926d17ea3e7c 2026-09-15T08:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-s-co-ceo-has-big-hopes-that-fibrosis-drug-can-reverse-aging-too-05298b94b951aeb6 2026-09-15T08:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/deutsche-bank-upgrades-astrazeneca-stock-rating-to-hold-on-trial-results-e24cf6dc3282e01a 2026-09-15T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-company-abec-opens-north-carolina-facility-35b14667e72d9b33 2026-09-15T08:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbsrc-publishes-refreshed-edi-action-plan-for-2026-to-2028-5b9f44f6886b921c 2026-09-15T08:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-28-09-02-10-h-open-week-malattie-cardiovascolari-84f3f324009bddd2 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/every-electron-counts-most-detailed-protein-structure-to-date-revealed-05e3072f40e0c0d6 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-guide-supply-management-critical-to-irt-trial-success-for-biotech-sponsor-ff618748e3e73b3e 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-s-dt120-odt-meets-primary-endpoint-in-phase-3-gad-study-ffdc87d33d747dda 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-just-handed-psychedelic-drug-sponsors-a-framework-now-the-hard-part-star-0df868a4710c99b2 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-company-uses-biotech-to-develop-more-effective-biological-pesticides-584a7468194ba384 2026-09-15T07:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-mourns-the-passing-of-prof-filipe-caseiro-alves-30d53a422912c304 2026-09-15T07:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-advanced-bhv-7000-to-pivotal-trials-without-answering-a-question-the-fd-8ef994cf536ab4e7 2026-09-15T07:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-ras-inhibitors-what-comes-next-in-pancreatic-cancer-ecf1adfe3a0130a8 2026-09-15T07:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hannah-benisty-and-maximilian-stammnitz-join-ar-i-crg-mountain-genomics-talent-p-4c62b23e8d169932 2026-09-15T07:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-nutx-8-iova-7-atrc-cnc-con-4690179e4c18e9cd 2026-09-15T07:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-facing-fda-decision-in-october-2026-32d5468f90b77d0b 2026-09-15T07:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genfit-plans-phase-2-liver-failure-trial-after-acquiring-immunomodulator-from-in-a5b612c6084d9b58 2026-09-15T07:02:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-created-digital-platform-nets-recognition-nih-grant-d95c7fa1ac47495b 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eur-and-erasmus-mc-once-again-achieved-nearly-100-open-access-in-2025-29ceeb281f399463 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-news-world-report-names-uc-davis-children-s-hospital-among-best-children-s-h-81eff130777decf6 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/northern-nevada-based-cancer-care-specialists-joins-uc-davis-cancer-care-network-7f2acb3d8d3957d1 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-wildfire-smoke-exposure-grows-uc-davis-researchers-seek-answers-92f9b79dafc9784f 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-creates-pathway-from-clarkson-college-to-unmc-pharmacy-programs-63ab3960072b2c50 2026-09-15T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/huons-teams-with-3-biotechs-on-mrna-adc-peptide-drug-projects-e922bd96adfa7ffa 2026-09-15T06:56:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-22-nhk-e-cdb01965a93c2f77 2026-09-15T06:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1bn-to-public-biotech-fund-taking-total-commitments-ff6f44cd37484361 2026-09-15T06:56:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/forsberg-event-captured-majesty-of-whooping-cranes-d2c7373c7604ca90 2026-09-15T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-eu-biotech-act-must-deliver-practical-improvements-for-clinical-trials-i-cd6fa0b28c6148ce 2026-09-15T06:55:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/durham-outpatient-center-circle-drive-to-update-striping-c98d347bad7d3824 2026-09-15T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sionna-to-test-sion-451-and-sion-2222-combo-in-cf-phase-2a-trial-502cb66a8d1bb08a 2026-09-15T06:48:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-invests-80-million-to-expand-biotech-production-in-slovakia-e5631308d237f1b5 2026-09-15T06:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/keeps-biopharma-s-idetrexed-wins-korean-phase-2-ind-approval-c048c54abe2e3304 2026-09-15T06:21:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-firm-boryung-to-split-off-sales-marketing-divisions-ef1110c02ba6eaa5 2026-09-15T05:49:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/purity-with-purpose-clariant-health-care-raises-the-bar-for-pharmaceutical-excip-ed1ca819e43d20f0 2026-09-15T05:28:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/gemeinsam-fur-ein-gesundes-uniklinikum-8e963b027cfbb561 2026-09-15T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-could-get-its-first-indigenous-dengue-vaccine-by-2027-icmr-dg-reveals-time-544de43e0a215d6e 2026-09-15T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-mochida-pharmaceutical-co-ltd-stocks-c9e7c6384cd77f6b 2026-09-15T04:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/esophageal-ph-monitoring-capsule-recall-medtronic-and-given-imaging-remove-esoph-d9cf1ce94eb38542 2026-09-15T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-10-000-patients-reveal-what-works-best-for-knee-arthritis-pain-relief-efa56f58b8e874fb 2026-09-15T03:57:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiny-cell-antennas-may-help-explain-why-some-babies-are-born-with-heart-defects-1e6857f6c530acbd 2026-09-15T03:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-native-biotech-yudao-bio-raises-30m-series-c-76640c7b47244685 2026-09-15T03:07:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/plague-was-killing-entire-families-thousands-of-years-before-the-black-death-d0f81adc1c6595ac 2026-09-15T02:54:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-vs-vertex-pharmaceuticals-value-stability-vs-high-growth-biotech-investmen-cf23a82612abdb43 2026-09-15T02:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/2027-5a1abac55f9bda0e 2026-09-15T02:36:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-nuclear-courses-to-power-south-australia-s-future-aukus-workforce-b519f116eb423145 2026-09-15T02:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-best-biotech-stocks-for-2026-and-how-to-invest-95a8df16f2907324 2026-09-15T01:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/test-seoul-biotech-startups-enter-boston-pipeline-through-labcentral-950b2083d7c96caf 2026-09-15T01:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-biopharma-complexity-why-long-term-partnerships-matter-39b1115d3c1f4806 2026-09-15T01:21:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/propriedade-intelectual-e-eficiencia-regulatoria-como-motores-do-bem-estar-regio-47eb0fde5a9a0cb3 2026-09-15T01:16:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-detection-biotech-lodges-patent-suit-against-rival-97957de1513c39f1 2026-09-15T01:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellectual-property-and-regulatory-efficiency-as-drivers-of-regional-well-bein-0e91412e61ed6c95 2026-09-15T01:04:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-from-the-fda-s-hearing-on-psychedelic-drugs-9a4b8269165dba38 2026-09-15T01:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bsr-sdic-biotech-seek-cooperation-on-ethanol-biofuels-96d7ccba31ab201d 2026-09-15T00:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-biotech-giant-lonza-breaks-ground-on-major-bend-expansion-6a4e618ea7fbf639 2026-09-15T00:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/propiedad-intelectual-y-eficiencia-regulatoria-como-motores-del-bienestar-region-636ab545130e30a3 2026-09-15T00:13:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-8a0e637c0b3e4dbe 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-6f021ed602180448 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-4bd9ab41996e78ab 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-botulinum-neurotoxin-into-anti-cancer-agents-a961c38b9f672a2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-hierarchical-genomic-framework-associated-with-response-to-braf-directed-thera-28c3a45aa18ad1e5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intracranial-recordings-in-humans-reveal-differential-contributions-of-medial-an-727fada75d1c43ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/broadly-neutralizing-antibodies-in-adult-males-living-with-hiv-undergoing-analyt-10c7cdd6ae46e688 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-breakthrough-for-ras-driven-cancers-fb8906a37f894648 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-premise-medical-ai-agents-for-reliable-clinical-decision-making-5faadfdcab1519ab 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-kras-g12d-inhibitor-gfh375-for-previously-treated-advanced-solid-tumors-wit-f3764900861d3f6e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-versatile-nanopore-identifies-four-classes-of-analytes-simultaneously-1d1ed26f07ad5c33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ensuring-safety-and-accountability-in-china-s-biomedical-translation-system-24d508374c9320bb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-control-of-glycogen-through-direct-ubiquitylation-by-rnf213-a40fb56dcdf3e131 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-erythropoietin-receptor-on-cdc1s-dictates-immune-tolerance-aef989b5d5a1aab5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-nepal-floods-resulted-in-a-disaster-even-after-satellites-spotted-danger-6e82321e44a67096 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-nih-must-resist-the-metrics-trap-087943e1f4f738fb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/make-ai-traceable-before-it-shapes-global-climate-assessments-095e20bfe46c840c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-wake-up-call-diversify-global-research-funding-ac1e73ac7378f0ac 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-inequality-panel-is-a-chance-for-research-to-change-lives-68c3c3d680dcc246 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cities-and-countryside-are-intimately-linked-green-initiatives-must-recognize-th-f1fff31fe0760c03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/underground-hydrogen-could-spur-a-green-energy-revolution-if-companies-can-find-afaa3b23ce54753f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-crops-are-coming-to-europe-why-bolder-would-be-better-ff5c4493589485dd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-geometric-genius-of-rene-descartes-3949e7d17149db6c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-80d5d3a67b0297db 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9794-4-crore-consolidated-revenue-and-e2-82-b9206-5-crore-o-75d6112bdcc05545 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-71349bc9aa23e66b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-olaparib-tablets-from-the-united-states-fo-f2d813da61b080d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-ab461ddce374a3af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-gets-approval-from-its-board-of-directors-for-increasing-it-1ad6db83fca4d7aa 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-completes-acquisition-of-additional-13-25-stake-in-adcock-i-f9efb9dd7fc1c8c4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-0cdd221cc37b19c3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-announces-conclusion-of-us-fda-inspection-at-visakhapatnam-428e762851cd6fcc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-1fb384b97542e0b3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-2769639a5b254ae5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-8f7ab7a97b96755e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investment-of-us-14-million-in-egenesis-inc-by-natco-pharma-canada-inc-and-natco-916c96d360b965db 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-page-024bdb231402bb6f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petition-048a-peripheral-artery-disease-findin-f6d3e799437ce4e2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petitions-048-and-051a-stroke-finding-of-insuf-75f442dab1d68f6e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-grant-of-an-exclusive-patent-license-development-and-commercializati-f2565eb7e1fb798e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-0626beb47d66f9d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-b8a95ad8905e26c2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-information-collection-activity-multistate-financial-institution-data-m-3021d4ff81f706b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-institute-notice-of-closed-meeting-421eb7f1bbe8c043 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-considerations-for-the-design-of-rare-disease-clinical-investigation-ebf052b141198824 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-knacka-hjartats-genetiska-kod-9a93a6184f8cdb67 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/till-minne-av-jan-ake-gustafsson-1943-2026-157d552849da7002 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-metod-minskade-aterfall-vid-formaksflimmer-15d874ef8dcb95f0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-undersoker-hur-dna-reparation-och-amnesomsattning-paverkar-immunsv-a92b2f175e0d7a03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-kartlagger-hjartskada-vid-svar-sepsis-14e2c43b092c5994 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/johan-askling-far-stipendium-for-patientnara-forskning-a73dfde5d21fffa7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hjarnans-blodflode-kopplas-till-trotthet-efter-covid-f64ebc22e61c93a4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-children-s-named-among-the-nation-s-best-children-s-hospitals-882b1ccab9ab1c35 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jama-8ec86eab73be8490 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/audio-highlights-august-21-2026-cdf70b6bc9b1aa3f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gestational-hypertension-has-increased-affecting-1-in-10-pregnancies-cd46702af2461f9d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-freeze-dried-plasma-product-in-the-us-91551b9c452b7fca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-drugs-linked-to-lower-fracture-risk-in-people-with-type-2-diabetes-ac0db8b55f56cfc2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-acetaminophen-and-naproxen-sodium-combination-drug-23f6a2ff6b0ab515 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-e-scooters-more-dangerous-than-motorcycles-and-bicycles-9309e6f9174b333c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aap-acog-speak-out-against-executive-order-fd97f969adb97da8 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-organoid-era-0d1d74c17c3dfac6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclospora-outbreak-reveals-gaps-in-foodborne-disease-surveillance-9c1923e37ef042aa 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-life-worth-saving-87e8ab3b696abb6d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-from-gut-hormone-discovery-to-a-public-health-revolution-dc098d40197dcc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-original-yes-66773534912b3190 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unspoken-7afae036d0f0f51f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healing-through-catharsis-in-poetry-c1c641915b1e651e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-to-inpatient-management-for-boarding-emergency-department-patients-4c8a954c5150c6af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-autonomous-ai-exceed-ai-aided-physicians-as-the-best-medical-care-f1019c797800d26e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-2af5f79a317fd31b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-reply-3b9c300a95d19024 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-guidance-for-author-use-of-ai-in-medical-publication-bb959e0d57595750 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-era-in-the-treatment-of-metabolic-dysfunction-associated-steatotic-liver-d-bc2991c82cd3907f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-and-safety-comparison-of-cycloserine-capsules-and-their-generic-b2e30b35cb0877d2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-treatment-adherence-among-patients-receiving-care-for-sexu-43adcc1d39fbcea3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adolescent-centered-cannabis-messaging-in-clinical-settings-preliminary-qualitat-b8d6c3a5e7c2239f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delays-in-malignant-neck-mass-diagnosis-missed-opportunities-in-clinical-decisio-9b3c51828bc44be9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-clinical-examination-for-detecting-knee-effusion-impac-faed480839f597f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-bioinformatics-to-decode-drug-resistance-and-guide-vaccine-design-in-6de558308b79a690 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/afp-commissioner-urges-conversation-about-link-between-australians-level-of-illi-928113742fc8c7bc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-signs-the-forgotten-art-part-3-ten-more-bedside-signs-every-clinician-s-dad7c35192128594 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-computer-aided-detection-for-adenoma-detection-promising-but-context-5c32ac5fe4accd6f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlations-of-the-expression-of-akap95-cx43-cpsf5-6-scffbxl2-and-scffbxo31-in-457d4f522a00c9ed 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-support-for-precolonoscopy-cancer-triage-a-rule-out-oriented-m-4254b4df21b60a7b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceptions-of-nursing-undergraduates-regarding-their-clinical-placements-a-qual-25bbee34a69cbf71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-factors-associated-with-anxiety-disorders-in-adults-with-childhood-hypo-f5f1bbf61b678653 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-bolus-sequential-triple-rule-out-ct-angiography-image-quality-and-radiati-2523fc6a940efa2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-there-a-way-to-break-the-glass-ceiling-in-the-diagnosis-and-treatment-of-extr-6dbfbb9ae0d485db 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychometric-evaluation-of-the-romanian-quality-of-life-in-adult-cancer-survivor-e4c61b7530a11b5d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-making-after-receptor-conversion-following-neoadjuvant-therapy-f9281e61f8e9684d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematological-versus-clinical-predictors-of-tumor-grade-in-endometrial-cancer-a-89a0af042aa922cc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathological-complete-response-and-residual-disease-patterns-after-neoadjuvant-c-938b06a557f15426 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psoas-compartment-block-versus-medial-branch-block-for-low-back-pain-a-narrative-c097443763d57ce9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-bdnf-in-subacute-stroke-effects-of-a-four-week-aerobic-exercise-interventi-4795366c5aa72614 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-and-ayahuasca-in-treatment-resistant-depression-clinical-evidence-met-a68c95b0c85d72ba 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ct-perfusion-guided-thrombolysis-in-the-extended-window-from-trial-eligibility-t-18ab636f06709701 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-clinical-and-structural-outcomes-of-a-standardized-ultrasound-guided-8cc2048e61bc5867 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/triglycerides-and-ovarian-response-in-diminished-ovarian-reserve-a-two-sample-me-719c3490b9f0ca02 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-modeling-of-small-molecule-pharmaceutical-solubility-in-324bb23bea21ac32 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reconciling-conflicting-evidence-on-stress-ulcer-prophylaxis-in-critically-ill-c-adbb7e278ab70fac 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-changes-in-serum-soluble-c5b-9-levels-following-immunomodulatory-th-ba34b9f9ee5c0b19 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patterns-of-scholarly-literature-use-in-health-sciences-theses-a-citation-analys-285cd602f16b2cf0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-changing-landscape-of-sudden-cardiac-arrest-in-young-adults-a-meta-analysis-fbbda51b82965c5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-survey-of-deep-learning-models-and-their-applications-in-text-recognition-98030a04077e78b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/need-assessment-of-oral-health-policy-curriculum-knowing-and-teaching-gaps-among-f665dec0108303b3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiographic-assessment-and-orthodontic-intervention-effects-on-orthodontically-a33f050d65702b81 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-course-and-management-of-pancreatic-pseudocyst-perforation-1451c95dbc284797 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ha-dmf-hybrid-attention-based-deep-matrix-factorization-for-drug-combination-syn-c24c4f1099f6ff20 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/latent-profiles-of-characteristics-related-to-humanistic-caring-ability-among-cl-0d8da2c3b8ec7537 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-mr-guided-focused-ultrasound-enhanced-liquid-biopsy-sonobiopsy-for-the-a28e33a00a204c71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/folic-acid-and-folate-6ec44d09f02a259d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-consuming-school-meals-enriched-with-fish-powder-on-zinc-status-of-sc-bcea81312a3014e4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-delivery-oriented-solubility-enhancement-of-curcumin-in-choline-chloride-ba-7f86f7046d0bf6bf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-simultaneous-aerobic-exercise-and-cognitive-training-in-persons-with-56b2210303292630 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryotkr-study-protocol-for-a-monocentric-randomised-controlled-trial-assessing-c-3ae306237195969c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-paradigm-for-treating-recurrent-platinum-resistant-ovarian-cancer-synergis-e57cce58ff1c8144 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-participation-in-breast-cancer-screening-through-a-tailored-reminder-l-af8d35afed59550e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-simvastatin-versus-calcium-hydroxide-intracanal-medications-on-postope-59c7eb81fdc92fb1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-everolimus-plus-exemestane-versus-fulvestrant-in-patients-w-c3c64b64c82bc02f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fresh-elective-single-versus-double-embryo-transfer-and-healthy-singleton-birth-d8684b6d846abf0e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-features-and-treatment-outcomes-in-erythema-elevatum-et-diutinum-a-syst-ac19a3d21703b2b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-to-clonal-expansion-of-alveolar-fibroblast-progeny-drives-pulmonary-fibr-44ff2f7168a840cf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrigendum-to-elevated-microrna-187-causes-cardiac-endothelial-dysplasia-to-pro-4c75f672d5d76622 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/going-to-the-source-pancreatic-lymph-nodes-maintain-stem-like-cd8-t-cells-in-hum-fcc64c04b96ae8b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-by-zhao-et-al-to-letter-regarding-article-dapagliflozin-to-reduce-early-015b0a731e1227ad 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-by-xu-et-al-regarding-article-dapagliflozin-to-reduce-early-recurrence-af-0c94dd0016b3241f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s5-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-c64c84a98cc49b03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s9-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-46b13aa809978329 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-molecular-and-clinical-determinants-of-targeted-therapy-treatment-in-b-d06dc5130b76a1b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-investigational-clinical-trial-agents-versus-conventional-second-salva-3384c787b95169af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s1-from-molecular-and-clinical-determinants-of-targeted-the-2e8b6f4b1a694aa3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s2-from-the-first-in-human-encit01-trial-comparing-second-v-096e4c3ff1996058 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s1-from-clinical-validation-of-a-multiplex-urine-biomarker-a-7c8fdcec85ec6c1f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/egfr-mutation-subtype-and-risk-of-brain-metastases-from-non-small-cell-lung-canc-43f1c6aa42c24d86 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/music-based-interventions-in-adult-stroke-rehabilitation-a-narrative-review-of-c-44e89f5c937bfc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eyes-reveal-systemic-secrets-diverse-systemic-associations-in-branch-retinal-f14042c63a7b3d2f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-integrated-approach-combining-receptor-based-ensemble-screening-and-i-in-vivo-69ead253511a7684 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-aluminum-oxide-nanoparticle-effects-on-camelina-sativa-pe-0f2efb614e70ad3b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimicrobial-stewardship-in-acute-exacerbations-of-copd-a-qualitative-study-of-0a4c60baff493e28 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-pharmacokinetic-and-pharmacological-profiling-of-b339-a-novel-sarm1-502265a87702e721 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-flexible-horizon-clinical-decision-support-model-for-dementia-early-detection-313a9702ec48c9d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-risk-profiles-of-heart-failure-and-non-heart-failure-major-adverse-card-6c2a7deeff11c8d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meteorological-factors-and-primary-care-consultation-patterns-in-rheumatoid-arth-4244589e5dac6fa5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-symptom-map-based-education-in-the-management-of-premenstrual-s-924bc4bf234159ed 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraocular-pressure-and-optical-coherence-tomography-parameters-in-pediatric-hy-a8a26bf8cc758a93 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transabdominal-lumbar-approach-tala-versus-retroperitoneal-approach-for-robot-as-35da7dabb4be8947 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decoding-nano-bio-interactions-gene-regulatory-networks-in-advanced-drug-loading-f65ffa6872396158 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2n-bots-a-dual-responsive-cross-scale-synergistic-strategy-for-hierarchical-drug-39e7bb594a62e3dd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guided-bone-regeneration-using-titanium-mesh-and-xenogeneic-graft-alone-histolog-9eaf093f0ac6237b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prescription-drug-use-among-us-adults-4ae68c0022c8c414 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-dose-intravenous-vitamin-c-and-mortality-and-organ-dysfunction-in-severe-bu-e3878b61ca52e0c3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821411-a-real-world-study-of-ofatumumab-in-multiple-sclerosis-patients-in-g-c3246e2c2eb31624 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821372-a-plant-based-diet-in-the-treatment-of-coronary-microvascular-dysfun-d655ef745e9b86ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820839-digital-stimulation-and-anxiety-and-sleep-quality-in-intensive-care-dfd765dc4e02acd3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820436-interactive-robot-guided-exercise-program-for-cancer-related-fatigue-28b46cb5a6ff0c06 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820345-development-and-evaluation-of-low-cost-non-animal-biological-simulat-a2263ed273f54b88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819812-thiotepa-based-conditioning-for-haploidentical-hsct-in-older-patient-19834e1645f4c992 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819669-video-assisted-thoracoscopic-surgery-combined-with-radiofrequency-ab-35c734308ccb4db1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819487-a-community-health-worker-service-to-address-acute-care-utilization-b002158db6f8417b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819474-optimizing-tumor-infiltrating-lymphocyte-til-harvest-site-and-patien-7b856cffb66c1902 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818590-the-effect-of-nanoparticle-coating-of-orthodontic-brackets-on-the-ra-45cd5b663cc584f2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816380-a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-jyp0322-in-642a98b45b02f543 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07811219-resp-fit-a-respiratory-muscle-strength-training-intervention-for-cop-72b0a308d3f1fc5e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794072-digital-patient-engagement-in-technology-supported-neurorehabilitati-4d24420e01be64f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07771439-a-study-to-investigate-the-efficacy-and-safety-of-belumosudil-compar-bb9961730e105b96 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07758543-combined-effects-of-proprioceptive-neuromuscular-facilitation-pnf-an-49d5ff3b502e2814 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07748403-a-study-of-the-safety-and-efficacy-of-prime-editing-pm577-in-partici-ea321f8bd62b726d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07687160-spiro-first-a-pragmatic-primary-care-embedded-pilot-trial-of-renin-g-4a0d9b3a533c4615 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07686380-il-15-superagonist-with-or-without-vaccine-in-biochemically-recurren-cfd5e39e4ab2fd00 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07605130-efficacy-and-safety-study-of-digital-cognitive-training-and-pcsk9-in-a328d58cb1f68e10 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07573462-a-study-to-learn-about-the-safety-of-an-expanded-pneumococcal-vaccin-78503e06c71ea34d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07548034-ultrasound-guided-needle-percutaneous-electrolysis-with-therapeutic-2d98465a53615160 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07455513-a-novel-tobacco-cessation-resource-for-smokers-with-a-diagnosed-or-s-babb569f21565b13 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07424677-study-of-saroglitazar-magnesium-for-pbc-patients-with-incomplete-res-04db30873bd4378a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07399730-ravulizumab-outcomes-in-polish-patients-with-ahus-627560c9e573fc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384195-a-study-to-assess-efficacy-and-safety-of-n-acetyl-ged-0507-34-levo-g-07f4a720d62cbd5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384052-safety-and-feasibility-of-intranasal-insulin-in-patients-with-spinal-67f5e5a3a02a354d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07223190-a-study-evaluating-subcutaneous-versus-intravenous-blinatumomab-in-n-5094280ab239ca2d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217704-using-18f-fapi-pet-to-detect-metastatic-disease-in-patients-that-hav-6a2e440643c6f86b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217223-spaced-transcranial-direct-current-stimulation-for-treatment-resista-a196dd6caa7e573c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07186673-hall-technique-vs-conventional-crown-restoration-in-permanent-molars-5c65b44ea921789e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07137442-distinguishing-tics-and-functional-tics-using-clinical-neurophysiolo-e0a0f7cc00953d72 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07111065-fast-for-dm-fatty-acid-supplementation-trial-fast-for-dermatomyositi-ed2b3f59cab40468 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07076888-aerobic-exercises-and-hemodialysis-patients-3a82acc449e28cf4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991751-a-natural-history-of-cardiometabolic-disease-among-us-bhutanese-deve-74080274b3baf1da 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06971601-diagnostic-validity-ofclinical-tests-for-infrapatellar-fat-pad-impin-6b42f1c6883002b2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06968195-autologous-car-t-cells-targeting-gpc3-rpcar01-for-the-treatment-of-a-d41a860ed00a1eb9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06909357-creation-of-an-infrastructure-to-support-delivery-of-mhealth-interve-91ee37745d2dd9cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06901531-a-study-of-zolbetuximab-together-with-pembrolizumab-and-chemotherapy-def392f8fcb82573 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06855498-rollover-study-for-participants-previously-enrolled-in-clinical-tria-6eaab02a97d67e85 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06687603-multi-site-detection-of-barrett-s-esophagus-in-patients-without-chro-06c9322cd8de53b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06642649-evaluation-and-comparison-between-general-anesthesia-vs-two-types-of-9dde98cb658819cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06615973-screening-for-social-determinants-of-health-sdoh-and-cognitive-funct-69af5e89852e6a1a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06487481-study-of-preoperative-radiation-therapy-in-participants-with-resecta-fc044139700317d0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06357377-a-study-of-the-safety-dosing-and-delivery-of-neo100-in-patients-with-729aeb3d065dda50 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06215118-a-study-to-learn-about-the-effects-of-the-combination-of-elranatamab-7661da673166f2fd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05854498-liposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-with-m-42ae3aeaaa80f865 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05800873-evaluate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-o-9b82b9f2b79798e1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05648500-a-research-study-to-evaluate-the-effects-of-a-new-oral-medicine-call-9fea27ee297e8372 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05646212-integrating-treatment-for-mental-disorders-in-methadone-clinics-in-u-9262aea7de481f33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05609630-study-of-oral-upadacitinib-and-subcutaneous-intravenous-tocilizumab-cf3986ca70e378eb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05593003-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-8192cb0cac23aaca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04969315-tt-4-and-tt-10-as-single-agents-and-in-combination-in-subjects-with-47e40ceba085b186 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03602092-observational-registry-data-on-gist-patients-c42decc4fe5bee88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03233347-doxorubicin-vinblastine-dacarbazine-brentuximab-vedotin-and-nivoluma-edfaf2b3161a17d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02974621-cediranib-maleate-and-olaparib-compared-to-bevacizumab-in-treating-p-7e4d87d92032d636 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01920737-a-novel-pediatric-inspired-regimen-with-reduced-myelosuppressive-dru-e45ceb892be60f2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00501800-genetic-epidemiology-of-ovarian-aging-eb1fa7f9595e246f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-should-increase-transparency-of-medicare-drug-rebate-not-undermine-ph-a001818b52e871a3 2026-09-14T23:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-invests-in-bend-with-new-spray-drying-pharmaceutical-facility-5ef61dcb2124809c 2026-09-14T23:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-dose-of-pharmaceutical-lsd-cut-anxiety-scores-five-points-below-placebo-1b96a9edbdfd9952 2026-09-14T23:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-8758d5eb9f517c42 2026-09-14T23:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-universidad-publica-como-infraestructura-de-futuro-b4147503f2b6cde1 2026-09-14T22:25:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-scivision-biotech-inc-stocks-389ec0e5dfc677b4 2026-09-14T22:22:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/click-e-stock-sk-biopharmaceuticals-no-adverse-reactions-in-over-1-200-clinical-6b7d899aeecf60d4 2026-09-14T22:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-responses-in-health-and-disease-un-encuentro-internacional-para-avanzar-04ce29e0296cd3e9 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-cultural-weight-of-a-psychedelic-approval-looms-fda-hearing-focuses-on-access-3dd0f695022b3990 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-21-09-fattori-di-rischio-e-differenti-scenari-nella-masld-una-sfida-quo-9e0383bb1de287ac 2026-09-14T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-manufacturing-exozymes-picks-curia-as-commercial-scale-manufacturing-part-8072a8f65738427c 2026-09-14T21:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/all-eyes-should-be-on-patient-centricity-in-clinical-research-04df9b05d4503427 2026-09-14T21:47:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-relationship-between-glp-1-use-and-trust-in-pharmaceutical-companies-dd4ad4ab4492d263 2026-09-14T21:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-community-credit-union-executive-to-lead-2026-heart-walk-and-citywide-push-3dc710a6d091f198 2026-09-14T20:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-a-potent-greenhouse-gas-into-a-valuable-pharmaceutical-building-block-us-c3c09f1b357c34f0 2026-09-14T20:20:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacyte-biotech-2026-revenue-0-net-income-5-79m-eps-0-54-10-q-summary-51393d86a7f3306b 2026-09-14T20:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-upcoming-launches-and-data-readouts-signal-a-major-4dc2a9d2d1a843d6 2026-09-14T20:07:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/pmcb-10-q-filings-pharmacyte-biotech-inc-sec-10-q-565620d7f0c71385 2026-09-14T20:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-200-long-covid-patients-joined-a-drug-trial-biovie-will-discuss-results-tu-67da8678a80a17b2 2026-09-14T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-full-year-2026-financial-results-and-provides-operati-951019e6c4827bd3 2026-09-14T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-medical-exhibits-prosense-cryoablation-for-breast-cancer-at-eusobi-2026-ddd8fe79c74d2705 2026-09-14T19:52:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-biologics-signs-usd-262-million-manufacturing-agreement-with-european-ph-fb7c4ed0f909f1f4 2026-09-14T19:48:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-major-launches-and-data-readouts-drive-a-pivotal-s-717627c4307b728c 2026-09-14T19:38:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-enters-rebrand-pharmexec-2c787093e950878f 2026-09-14T19:34:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/avoiding-a-sticky-situation-how-cells-stop-messenger-rnas-from-clumping-together-744314666fbd69b8 2026-09-14T19:26:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-and-warnings-zicam-nasal-swabs-recalled-foreign-pills-found-in-trazo-5ad8aa6171d7227b 2026-09-14T19:21:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-apptec-hires-sander-lurie-on-health-issues-b699ab16252ac6c6 2026-09-14T19:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-tuberculosis-vaccine-enters-phase-3-trials-cd8a20823059bee8 2026-09-14T19:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelics-are-wall-street-s-next-trip-why-this-biotech-stock-is-already-up-20-52049d1cb6186539 2026-09-14T19:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/with-just-6k-left-nymox-pharmaceutical-nymxf-discloses-doubt-it-can-keep-operati-e8db46bea5f1a743 2026-09-14T19:08:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-covid-vaccine-was-a-historic-success-could-its-cancer-vaccine-be-even-1cd1b0f3582ae845 2026-09-14T18:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-b5f7831b8f22e544 2026-09-14T18:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-raises-11-3-million-in-initial-pipe-led-by-patrick-soon-shiong-2a0574d4a6e16d59 2026-09-14T18:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-to-hold-psychedelic-drug-hearing-amid-trump-push-what-it-means-for-depres-533440f01f0e6121 2026-09-14T17:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fda-hepatic-impairment-guidance-what-it-means-for-your-next-dedicated-study-304156041da363ea 2026-09-14T17:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-krystal-biotech-krys-cheap-on-its-cantor-conference-spotlight-0c18fece4209bc40 2026-09-14T17:38:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-unlp-ya-es-una-referencia-nacional-en-transparencia-institucional-ba6b96c70772a12a 2026-09-14T17:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-escuela-anexa-celebro-sus-120-anos-9c879903459bdbec 2026-09-14T17:35:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-unlp-busca-actualizar-el-sistema-de-boleto-educativo-gratuito-23085b598b2c352d 2026-09-14T17:35:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-investigacion-en-ciencias-juridicas-y-sociales-ed533927705db35a 2026-09-14T17:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-raises-cullinan-oncology-stock-price-target-on-trial-data-22cf64853e80f8c8 2026-09-14T17:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-updates-for-apple-s-software-platforms-are-now-available-7e168732e05224a3 2026-09-14T17:10:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/siri-ai-a-profoundly-more-capable-and-personal-assistant-is-here-f931fcd3fd7e990f 2026-09-14T17:09:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/gensci-registers-phase-i-trial-of-four-target-retinal-fusion-protein-across-thre-b4aea070a721fd83 2026-09-14T17:09:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-s-new-child-safety-features-now-available-926b88dd00a7451e 2026-09-14T17:08:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-cans-early-experimental-obesity-drug-after-high-bar-not-met-778b1d9c286a2c43 2026-09-14T16:45:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-naomi-running-strong-with-latent-autoimmune-diabetes-in-adults-9fcf72340a5b9eb4 2026-09-14T16:38:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogren-s-investors-c33dcbb7609e0cdd 2026-09-14T16:37:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/minnesota-farmers-ride-crop-price-highs-could-lofty-diesel-costs-hurt-profits-30afa337a011edc2 2026-09-14T16:26:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-audit-shows-that-minnesota-s-assisted-living-reforms-are-working-99b1842c3d61b697 2026-09-14T16:26:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-jimmy-kimmel-and-disney-learned-to-fight-trump-76dfa04bfbd169cb 2026-09-14T16:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/not-glamorous-but-common-how-to-manage-dandruff-at-home-and-when-to-get-help-f4a7983579c5cf59 2026-09-14T16:24:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-what-is-behind-the-fresh-attention-4d40e1b350ba2828 2026-09-14T16:24:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-a9e99d59823fe228 2026-09-14T16:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-day-at-camp-discovery-base-at-beaumont-05644ac40d5a0317 2026-09-14T16:17:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/tauber-y-katopodis-evaluan-obras-y-proyectos-para-la-unlp-10e53f4171c31b4a 2026-09-14T16:16:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/send-and-receive-information-on-adverse-drug-reactions-adrs-4920109ea3e981a5 2026-09-14T16:11:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-ada-family-day-at-the-louisiana-children-s-museum-e820ec776aac4f44 2026-09-14T16:09:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-screening-cooperation-for-efficient-processes-and-digital-networking-fd28a98854e7f430 2026-09-14T16:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/promising-biotech-stocks-to-follow-today-september-14th-ef83ca4efd667b1b 2026-09-14T16:04:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-pharma-accelerating-development-with-microsoft-the-microsoft-cloud-blog-484d640992178bbb 2026-09-14T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-path-to-stability-at-fda-188b02c94a11daad 2026-09-14T15:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/divided-we-fall-new-book-explores-polarization-citizenship-and-canada-s-democrat-7782838c31c3bd75 2026-09-14T15:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extracting-cbd-from-artisanal-practice-to-industrial-production-ccc31add2fafeeeb 2026-09-14T15:51:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-reports-earnings-results-for-the-half-year-ended-j-da34acb47d55b873 2026-09-14T15:50:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/transferencia-a-municipios-facultad-de-humanidades-y-ciencias-de-la-educacion-9540240688faf000 2026-09-14T15:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-mln-pipe-financing-b6b99a80672f80c4 2026-09-14T15:37:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-reports-initial-closing-of-private-financing-6a8c3eab1e9ee839 2026-09-14T15:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-more-nordisk-novo-s-latest-trim-is-in-its-name-ac18f90a0e95918d 2026-09-14T15:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-partial-clinical-hold-on-biohaven-s-epilepsy-drug-days-after-795-mill-fb310141e51e479d 2026-09-14T15:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/severine-technicienne-de-laboratoire-2c74bfe257c1dad0 2026-09-14T15:23:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/souraya-technicienne-de-fabrication-9d9c0b4535f10a0f 2026-09-14T15:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-2026-to-2027-quarterly-da-854a7f00c802afc8 2026-09-14T15:13:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-biotech-industry-trends-reshaping-the-healthcare-market-1fff79779a254128 2026-09-14T15:13:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fabien-pharmacien-3a609789b2007f1e 2026-09-14T15:11:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-public-appointments-2026-to-2027-92f3e9c4047ba1dc 2026-09-14T15:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-seeks-to-raise-150m-for-drug-development-93d25e67402257ae 2026-09-14T15:07:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/midcap-biotech-outlook-cmps-leads-on-trend-momentum-and-catalyst-timing-9644863c7fee914b 2026-09-14T15:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-2025-bb92cb39bafb6027 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saved-by-cpr-at-15-college-freshman-leads-walk-to-build-a-nation-of-lifesavers-029ca01991841a12 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-scientists-uncover-why-some-huntington-disease-patients-decline-years-earlie-a58ece91b665ae4b 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacometric-analysis-of-givinostat-to-support-individualized-dosing-recommend-ee9f071f11247a73 2026-09-14T14:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-medicine-57c9c5f343002163 2026-09-14T14:54:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengue-the-green-book-chapter-d659d5bcdd75ad40 2026-09-14T14:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-grants-priority-review-to-zasocitinib-for-moderate-to-severe-pso-1e9daa76b6caf233 2026-09-14T14:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-is-rising-in-younger-adults-faster-biological-aging-may-help-explain-why-af5b408f41983ad4 2026-09-14T14:47:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-million-pipe-financing-and-t-ca8e381455767ccd 2026-09-14T14:43:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-raises-11-3-million-in-initial-closing-of-pipe-led-by-nant-cap-920b0390e9a9b55d 2026-09-14T14:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gustave-roussy-et-the-lancet-lancent-une-serie-de-conferences-internationales-su-4e55915d5469cf26 2026-09-14T14:39:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-government-response-to-the-covid-19-inquiry-module-3-report-82255ac20476e0dc 2026-09-14T14:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-ambition-to-delivery-is-the-national-cancer-plan-properly-funded-9c09e27be00761eb 2026-09-14T14:32:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cancer-biotech-raises-11-3-million-the-los-angeles-times-owner-joins-its-board-36c5c0123605f906 2026-09-14T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gotistobart-lung-cancer-drug-candidate-prolonged-lives-in-trial-8e786176d108948a 2026-09-14T14:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/hidden-brain-wiring-may-help-keep-the-mind-sharp-as-gray-matter-shrinks-36b53f1bb0d841b7 2026-09-14T14:23:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-therapeutics-dftx-stock-soars-20-on-successful-phase-3-anxiety-trial-re-b93947691e55d7f8 2026-09-14T14:23:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevenzione-dei-tumori-testa-collo-torna-la-make-sense-campaign-9cd20a882d33d472 2026-09-14T14:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/stifel-cuts-olema-pharmaceuticals-price-target-on-trial-concerns-by-investing-co-aff64a0df39e3aa2 2026-09-14T14:19:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-selected-as-new-home-of-uc-global-health-institute-56cd186455bc9ef2 2026-09-14T14:17:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivek-malhotra-awarded-the-febs-theodor-bucher-lecture-and-medal-2027-5ccbb2fe92bb7765 2026-09-14T14:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/nifst-stakeholders-seek-evidence-based-regulation-of-low-calorie-sweeteners-85989083eb27fcb7 2026-09-14T14:12:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-appoints-robert-plenge-to-board-of-directors-b4f7261b09af2577 2026-09-14T14:09:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunocore-achieves-full-enrollment-in-phase-3-tebe-am-melanoma-study-16e530c8f0b3f5f0 2026-09-14T14:02:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/alert-carolina-sirens-test-to-be-held-sept-17-d26cf30858dae636 2026-09-14T14:02:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezilient3-trial-efficacy-and-safety-data-of-zipalertinib-in-egfr-exon-20-insert-781f2e368253f241 2026-09-14T14:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/recce-pharmaceuticals-asx-rce-phase-3-diabetic-foot-infection-trial-and-mena-lic-38124a0b87aac230 2026-09-14T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-cause-of-high-blood-pressure-that-routine-tests-can-mis-60abf91e63ce05b8 2026-09-14T13:57:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-e256990a7d983a8b 2026-09-14T13:54:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-fortalece-cooperacao-com-centro-educacional-da-china-127812ec28885465 2026-09-14T13:52:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-are-embl-pierre-chazelas-on-connecting-people-to-support-science-758939b5b4ff1538 2026-09-14T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-insider-trading-activity-2026-249623a1453a3bf2 2026-09-14T13:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-touts-lung-cancer-data-from-two-drugs-8d677a7a22389a58 2026-09-14T13:38:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/seminar-on-religions-and-beliefs-in-the-city-possibilities-practices-and-problem-d99b952e59707309 2026-09-14T13:38:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bringing-a-high-potential-bispecific-back-from-the-brink-22fd8da9d83fa842 2026-09-14T13:32:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-growth-trust-extends-strong-performance-in-2026-d9b4635f68450caa 2026-09-14T13:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-and-lesotho-strengthen-regional-collaboration-for-regulatory-excellence-45f1f401fec36a52 2026-09-14T13:23:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cu-anschutz-scientists-discover-why-shingles-pain-can-last-after-virus-is-gone-cd4689c91381e211 2026-09-14T13:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-at-morgan-stanley-conference-growth-broadens-fe0c6b0b57907f44 2026-09-14T13:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edoardo-porro-il-pioniere-dell-ostetricia-che-ha-rivoluzionato-il-parto-e-ispira-a84e601e62ba77d6 2026-09-14T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-great-repricing-seven-assumptions-that-no-longer-hold-f2ecd76baf8525c8 2026-09-14T13:13:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-dr-michael-c-burgess-we-need-a-new-playbook-to-guard-against-counterfe-ac7bd868d307f45e 2026-09-14T13:09:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2019-to-2023-800293e4e71f3202 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-inc-nasdaq-bmrn-appoints-bms-r-d-chief-robert-plenge-to-d11aa567c7551aa2 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skontaktuj-sie-z-nami-90650b1f2a327e6a 2026-09-14T13:03:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cells-that-help-the-tumor-the-family-history-of-tregs-reconstructed-2b4eb336a58ed5a6 2026-09-14T13:02:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/wysokiej-jakosci-sterylne-ampu-ki-dla-przemys-u-farmaceutycznego-2b9391d5780cc4b9 2026-09-14T13:02:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rabies-post-exposure-risk-assessment-d5bf37390bb160f1 2026-09-14T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/krtl-biotech-appoints-federal-controlled-substance-compliance-specialist-justin-4350832aa88145f3 2026-09-14T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dare-bioscience-announces-peer-reviewed-publication-of-phase-1-sildenafil-cream-05d0eae494a7f684 2026-09-14T12:59:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyle-hurysz-prepares-for-career-in-business-law-2b6b87d474bcf87d 2026-09-14T12:58:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/organon-announces-us-fda-has-accepted-for-review-a-supplemental-new-drug-applica-6c0c0422506d902f 2026-09-14T12:57:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/radio-astronomer-takes-skynet-closer-to-hearing-the-universe-769cec1e800ef6af 2026-09-14T12:55:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-aims-for-342m-ipo-to-power-inflammatory-drug-s-push-through-phase-3-0240e717903fd159 2026-09-14T12:52:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-strange-link-between-low-vitamin-d-and-pain-40b149eb395340fe 2026-09-14T12:52:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-small-drug-stocks-poised-to-benefit-from-a-biotech-recovery-570bf916e68b800a 2026-09-14T12:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/contattaci-9aceed417471446a 2026-09-14T12:47:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ampolle-sterili-di-alta-qualita-per-l-industria-farmaceutica-4fbfcda611c6fce7 2026-09-14T12:46:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-looking-to-offload-orthopedics-unit-in-20b-deal-to-apollo-bloomberg-dc98416c34c5142a 2026-09-14T12:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-quality-sterile-ampoules-for-the-pharmaceutical-industry-ab5de1c491afce3f 2026-09-14T12:39:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/gatc-health-joins-critical-path-institute-s-new-approach-methodologies-developer-05166a46c1038966 2026-09-14T12:38:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiff-oncology-and-nerviano-medical-sciences-amend-their-2017-exclusive-licens-5715a4c53623c959 2026-09-14T12:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-monthly-fact-sheet-as-at-31-august-2026-a063b8d62d709d23 2026-09-14T12:38:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/etra-ipo-news-antibody-biotech-electra-therapeutics-sets-terms-for-325-million-i-0ecc46d14794d0ab 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/geovax-and-cepi-enter-agreement-to-utilize-cepi-centralised-laboratory-network-t-68dec5d4551f2cf9 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ampoules-steriles-de-haute-qualite-pour-l-industrie-pharmaceutique-d098a37d66a079a7 2026-09-14T12:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-cancer-drug-rights-dispute-settled-by-cardiff-and-nerviano-21e0f50be19d2e22 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-5184e9ed11a3026d 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-nasdaq-bntx-lung-cancer-drug-extends-survival-vs-chemo-in-phase-3-c6832e849c4d7d59 2026-09-14T12:29:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-shift-in-biotech-manufacturing-canva-0f67a9758151f283 2026-09-14T12:28:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-research-to-improve-k-12-stem-learning-gets-funding-boost-e69bf6987ccd6e3b 2026-09-14T12:23:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/biographie-jeremie-calais-170c54ede4f814fa 2026-09-14T12:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/leios-therapeutics-announces-positive-end-of-phase-2-meeting-with-fda-for-10xb-1-573671facadcb78f 2026-09-14T12:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/pulsed-field-ablation-for-perimitral-atrial-flutter-with-involvement-of-the-vein-3053caae0965f2e5 2026-09-14T12:11:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-and-autoimmune-trials-define-legend-biotech-legn-cell-therapy-pipeline-e925d7051366c5a6 2026-09-14T12:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/briacell-bctx-phase-3-trial-safety-endorsement-highlights-market-s-cautious-outl-2ca36055c44df42a 2026-09-14T12:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-ethanol-infusion-via-the-vein-of-marshall-on-atrial-tachyarrhythmia-wi-f49a7307965e473a 2026-09-14T12:05:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-safety-monitoring-board-recommends-continuing-briacell-s-phase-3-metastatic-00b5e7c605eb755f 2026-09-14T12:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/correcting-false-health-claims-and-navigating-ai-generated-information-the-monit-4519fa1f68040a9e 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tzield-teplizumab-and-the-risk-of-viral-reactivation-fc9f7bdef9b658ae 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-48-hour-home-treatment-for-postpartum-depression-enters-a-new-study-about-120-6e444e94543dfa0a 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-brain-implant-lets-paralyzed-people-both-talk-and-gesture-via-an-avatar-53827898d51fb7ec 2026-09-14T11:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visit-from-the-university-of-washington-307d6656762b3b84 2026-09-14T11:48:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-slumps-as-legal-scrutiny-hits-phase-3-trial-1f83efc08a3e0313 2026-09-14T11:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-food-and-drug-administration-seizes-unsafe-dairy-products-e5136b5fcb9275cd 2026-09-14T11:43:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/etf-movement-china-asset-management-hang-seng-biotech-etf-03069-surges-over-4-am-2b7d5a6e5fdce085 2026-09-14T11:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-launches-exchange-offer-to-complete-separation-of-minimed-group-inc-e382312e420e5aaa 2026-09-14T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-breast-cancer-trial-gets-a-seventh-recommendation-to-continue-5b0431d8e7492c3c 2026-09-14T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/field-safety-notices-7-september-to-11-september-2026-593a20d84f2235c2 2026-09-14T11:25:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-nasdaq-bmrn-forms-tight-breakout-setup-with-strong-techn-8e3a96b30e8b630e 2026-09-14T11:20:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmazz-inc-receives-u-s-fda-orphan-drug-designation-for-sovateltide-for-the-tr-a207e4ccbfb768c7 2026-09-14T11:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunocore-announces-target-enrollment-achieved-in-phase-3-tebe-am-trial-of-kimm-23a53a59beab5bbe 2026-09-14T11:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-anxiety-treatment-met-every-key-goal-in-a-late-stage-trial-an-fda-meeting-is-0e9b1cfebc675f16 2026-09-14T11:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/nmn-2026-9-14-ceda7cee25400dc0 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-ag-biotech-company-plans-north-american-headquarters-in-indiana-4a390f206c0be123 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-therapeutics-announces-positive-topline-results-from-phase-3-panorama-s-2905618d20aa212a 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-stock-holds-near-highs-after-strong-quarterly-beat-and-fresh-a94b2b2446bb6792 2026-09-14T10:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-lsd-drug-goes-3-for-3-with-another-pivotal-anxiety-trial-win-fdd1cdfaac12bcca 2026-09-14T10:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/162-million-boost-for-vital-uk-life-sciences-and-materials-research-235994a400950216 2026-09-14T10:54:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-s-muscle-targeting-sma-therapy-isemblyd-lands-fda-approval-0c43d37e656f57b8 2026-09-14T10:50:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-advances-intelligent-robotics-to-transform-the-future-of-pharmacy-care-at-fai-6ee22ebbf5529230 2026-09-14T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-income-stocks-to-buy-for-september-14th-8c2cf2061f8628db 2026-09-14T10:44:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/stifel-cuts-olema-pharmaceuticals-price-target-on-trial-concerns-0d5c9b3f2acc7cac 2026-09-14T10:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-deepens-us-bet-with-commercial-plant-in-oregon-a29a78ec68bd0365 2026-09-14T10:40:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-telix-s-brain-cancer-imaging-drug-pixclara-449ed5b34cc35511 2026-09-14T10:34:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-accepts-new-drug-application-under-priority-review-for-takeda-s-zasociti-66c11273bfee998e 2026-09-14T10:31:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/alcon-warns-that-us-proposal-could-cause-companies-to-abandon-europe-53d56b7bd75bdab8 2026-09-14T10:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-s-proposed-drug-ad-rule-is-a-blueprint-for-violating-the-first-amendment-7fa4cc4a983c3d2f 2026-09-14T10:30:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-clinical-trial-attacks-pancreatic-cancer-with-laser-light-50201537c62719b8 2026-09-14T10:30:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-priority-review-to-takeda-nyse-tak-pill-for-severe-psoriasis-d7295820babd3de5 2026-09-14T10:26:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-rehabilitation-gym-on-hospital-ward-to-help-speed-up-recovery-4acf1c7f7d1c1105 2026-09-14T10:16:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-provides-keytruda-at-no-cost-for-a-cancer-trial-7d3d50d0d822e36e 2026-09-14T10:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-tumor-dna-guided-de-escalation-or-escalation-of-adjuvant-therapy-in-6efa02bc12c5e37f 2026-09-14T10:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/morocco-s-pharmaceutical-trade-deficit-to-reach-1-4-billion-by-2030-9d175f14f5356cfb 2026-09-14T10:10:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/speaker-fees-and-buy-and-bill-keep-doctors-loyal-to-pharma-0bcba66a606f3cfa 2026-09-14T10:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-fragmented-contract-processes-are-slowing-pharmaceutical-operations-cd7413f3e757257d 2026-09-14T10:06:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-western-mass-be-to-food-s-future-what-boston-is-to-biotech-umass-is-bettin-6f37059da1382faf 2026-09-14T10:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-corruption-is-structural-systemic-and-profitable-new-rev-b115c9249c53f64e 2026-09-14T10:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-makes-16-5-half-year-return-as-surge-in-listed-drug-developers-outwe-edb7b30944ab4575 2026-09-14T09:54:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-notches-ph-3-lung-cancer-win-but-trails-gsk-on-survival-fc45ac29de42f42d 2026-09-14T09:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-fourth-ukrainian-pharmaceutical-warehouse-has-burned-in-a-russian-strike-since-6eb47225c106b55a 2026-09-14T09:41:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-supplement-formulators-can-borrow-from-pharmaceutical-delivery-science-f3579b8398254e3c 2026-09-14T09:39:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pm-stresses-strengthening-egypt-s-pharmaceutical-industry-regulatory-system-8e45ce9f3a140f23 2026-09-14T09:33:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-2026-q2-results-earnings-call-presentation-otcmkts-fcb651dd64e3d3c2 2026-09-14T09:31:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-at-scale-how-the-boom-in-semaglutide-is-reshaping-cold-chain-packaging-dc829a089b2d700f 2026-09-14T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gotistobart-nearly-doubles-survival-in-pretreated-squamous-lung-cancer-838a3314261d298d 2026-09-14T09:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-drug-policy-may-raise-south-korea-prices-57fd68f8da342994 2026-09-14T09:24:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ganpati-prasad-under-fda-watch-maharashtra-societies-told-to-follow-new-food-saf-630ea4175c9525b9 2026-09-14T09:21:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-wins-fda-approval-for-isembyld-6fd7f56f5e278d83 2026-09-14T09:18:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-the-exit-ip-strategy-for-venture-backed-biotech-patent-united-kingdom-90eb104909dcff8f 2026-09-14T09:13:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/act-align-accelerate-europe-s-biotech-turning-point-aad0b26991fea488 2026-09-14T09:03:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/confirmatory-evidence-for-all-fda-s-approval-of-lytenava-for-wet-amd-shows-how-n-40abfb0b46f31586 2026-09-14T09:03:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-mois-de-sensibilisation-aux-cancers-du-sang-un-don-de-soi-au-benefice-a64c10f00e1b7c23 2026-09-14T09:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/spain-pushes-eu-wide-market-access-toolbox-for-innovative-biotech-medicines-830f72c452b45ef1 2026-09-14T09:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-has-a-chokehold-on-your-medicine-cabinet-it-s-a-national-security-threat-b390c227c0199626 2026-09-14T09:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-and-mdic-launch-efs-explorer-to-streamline-early-feasibility-study-site-c08463bbda9d1653 2026-09-14T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aortic-structure-may-affect-midlife-rise-in-pulse-pressure-aortic-stiffness-in-w-885a55e18f82e78f 2026-09-14T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/miten-autoritaarinen-venaja-on-selviytynyt-talousvaikeuksistaan-sodan-aikana-0904036d02c22876 2026-09-14T08:54:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/endometriose-les-hus-font-evoluer-la-prise-en-charge-des-patientes-577022fed901a9a3 2026-09-14T08:50:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-blijft-bij-europese-top-in-life-sciences-maar-europa-verliest-de-innovati-4a7b735814fa31da 2026-09-14T08:48:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-stocks-rise-on-monday-on-tech-biotech-gains-trigiant-jumps-47-98c47dac2ec6c611 2026-09-14T08:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-says-lung-cancer-drug-candidate-prolonged-lives-in-trial-bb6ddfdd81a51991 2026-09-14T08:36:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-prefix-is-no-shield-against-confusion-delhi-high-court-protects-biochem-eb4e0aa061fc398a 2026-09-14T08:31:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-says-lung-cancer-drug-candidate-prolonged-lives-in-trial-048c025d7109ee38 2026-09-14T08:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-our-tax-system-so-complicated-ad58788275115c48 2026-09-14T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026-72c636c8940d0e12 2026-09-14T08:29:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-will-adapt-to-the-changing-healthcare-market-with-a-new-visual-identity-f1df41c04eb14b89 2026-09-14T08:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentation-du-futur-chantier-des-facades-garonne-de-la-grave-a-la-fondation-du-b3785df73f23ae8c 2026-09-14T08:27:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-trump-s-pharmaceutical-plan-threatens-europe-higher-drug-prices-and-delays-i-50b78795a90ba91a 2026-09-14T08:20:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-strikes-fourth-ukrainian-pharmaceutical-warehouse-in-september-video-ed18c40308c28339 2026-09-14T08:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/prestigious-fellowship-to-uncover-how-our-gut-microbiome-tackles-dietary-xenobio-f2b2dd7865722ae7 2026-09-14T08:15:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-and-oncoc4-report-updated-phase-3-data-showing-gotistobart-nearly-doubl-32e2f4d485c7d29e 2026-09-14T08:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiho-pharmaceutical-co-ltd-taiho-oncology-inc-and-cullinan-therapeutics-inc-rep-f211a6db7e1ef0dd 2026-09-14T08:05:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/quarterly-epidemiological-commentary-mandatory-mrsa-mssa-and-gram-negative-bacte-476c46b5e267decc 2026-09-14T08:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-s-gotistobart-a-breakthrough-in-lung-cancer-treatment-3d84066f3e6cd42a 2026-09-14T08:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-s-experimental-treatment-extended-survival-to-18-5-months-versus-10-0e0798bc527d2105 2026-09-14T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivian-l-borrero-rac-achieves-recognition-for-40-years-of-leadership-and-contrib-24dc3b41c574ff62 2026-09-14T07:57:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/amivantamab-plus-chemotherapy-achieves-34-3-month-os-in-egfr-exon-20-insertion-l-0da3afd250e51aeb 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/tam-peli-extends-survival-to-13-3-months-in-relapsed-small-cell-lung-cancer-353338a24f94a9c6 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/mri-surveillance-alone-outperforms-mri-plus-radiation-in-sclc-trial-d1b659ade107b12a 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/emmaus-cedars-sinai-extend-pact-b072a5bba6875f3f 2026-09-14T07:38:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/challenges-facing-chinese-biotech-deals-de6788d32d76210d 2026-09-14T07:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korean-pharmaceutical-company-plans-to-produce-medicines-in-kazakhstan-2b892242f692f4bd 2026-09-14T07:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/kazakhstan-and-south-korea-agree-on-joint-pharmaceutical-production-7d2e8b6386b25bcf 2026-09-14T07:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-s-zasocitinib-wins-fda-priority-review-in-bid-to-redefine-oral-psoriasis-3f04a01589462c27 2026-09-14T07:34:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/kazakhstan-and-south-korea-agree-on-joint-pharmaceutical-production-fed78451972c2e24 2026-09-14T07:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-is-what-rotterdam-needs-to-become-the-best-city-in-which-to-grow-up-98f022969713553c 2026-09-14T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spotlight-on-innovative-pharmaceutical-companies-after-drug-pricing-reform-alteo-9d24cab8a2d849de 2026-09-14T07:20:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-new-brain-cancer-imaging-agent-from-telix-dfce838ed16dbfa7 2026-09-14T07:07:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/90-ad4b01e1c266920a 2026-09-14T07:04:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-breaks-ground-on-infectious-disease-air-transport-training-facility-2010e80ea80d1c22 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-started-getting-migraines-when-i-was-only-seven-083db6cc3484ec92 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-accepts-new-drug-application-under-priority-review-for-takeda-s-zasociti-ef17f61352cd7eaa 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spirit-halloween-raises-funds-for-uc-davis-child-life-81066505649e810d 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statement-on-pabs-instrument-at-the-eighth-meeting-of-the-intergovernmental-work-46d8f7c7cf3e1461 2026-09-14T06:58:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/legislative-candidate-ted-japp-visits-unmc-dfcea6c205f2e2ee 2026-09-14T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/employee-giving-campaign-begins-today-8584d75a826f93b0 2026-09-14T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nu-deal-cohort-announced-for-2026-28-671ca6628c037e1b 2026-09-14T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminart-resultat-i-regionvalet-4d0566344a58c227 2026-09-14T06:53:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-drug-plan-could-prompt-companies-to-raise-prices-outside-the-us-86468b2325ec3197 2026-09-14T06:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/yusheng-wu-will-defend-his-phd-thesis-7dce26de2d50c7f5 2026-09-14T06:51:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenya-explores-merck-partnership-in-biotechnology-and-local-pharmaceutical-manuf-4e4830bb94d8ddf5 2026-09-14T06:51:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-faculty-spotlight-sunandini-sharma-phd-95f639e9359ef0fc 2026-09-14T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nouveau-guide-destine-aux-promoteurs-pour-la-procedure-synchronisee-des-etudes-c-bf1ed68763a3326d 2026-09-14T06:48:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/trastuzumab-botidotin-shows-11-1-month-pfs-vs-t-dm1-in-phase-3-trial-564267db7516eeaa 2026-09-14T06:43:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-biotech-catalysts-to-watch-this-fall-rare-rapp-and-pcvx-nasdaq-rare-b87c087230a5836e 2026-09-14T06:37:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-pharmaceutical-new-drug-application-filing-accepted-for-review-in-china-f-5a0a1f604c868dd6 2026-09-14T06:37:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-6-d8d8ed54ead18b74 2026-09-14T06:35:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fourth-russian-attack-on-pharmaceutical-warehouse-this-month-facility-on-fire-in-fe9e711ab6f60d1d 2026-09-14T06:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/huons-teams-up-with-three-biotech-startups-for-joint-new-drug-development-expand-79cfd35f6eadf712 2026-09-14T06:33:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ad0e5b477a2967ca 2026-09-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personnel-changes-7dcc223d059f37ef 2026-09-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guide-destine-aux-promoteurs-pour-la-procedure-synchronisee-des-etudes-combinees-d566a9c40a897724 2026-09-14T06:22:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/9lione-a-pharmaceutical-distribution-dx-company-raises-120-million-in-series-a-l-977358ce07543d12 2026-09-14T06:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-reports-august-nav-of-2-92-per-share-by-investing-com-f389326bb2eef80a 2026-09-14T06:10:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-appoints-mats-blom-to-the-board-of-directors-as-chair-of-audit-committee-9cdbf75a711b7e6c 2026-09-14T06:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-rtw-biotech-opp-monthly-valuation-update-and-factsheet-2f129452d79a9f29 2026-09-14T06:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/violetta-zujovic-les-neurosciences-sur-plusieurs-fronts-f54a85ba6105ae1d 2026-09-14T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yuhan-corporation-unveils-clinical-trial-design-for-oral-her2-cancer-drug-yh4294-e92301864336810f 2026-09-14T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-wild-dogs-have-traveled-farther-than-any-african-mammal-867a0a8c1aeba3fc 2026-09-14T05:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-delays-review-of-exelixis-zanzalintinib-by-3-months-no-new-safety-issues-fou-406d52a642bf2331 2026-09-14T05:44:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewon-pharmaceutical-hosts-vietnamese-delegation-at-smart-factory-c66774a452dccbe7 2026-09-14T05:37:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/223-10-7-39c7257649d8d3fd 2026-09-14T05:29:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/lauf-gegen-krebs-geht-in-die-13-runde-b1998729cab447d9 2026-09-14T05:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-cmg-pharmaceutical-co-ltd-krx-058820-402e367de1aa6bfc 2026-09-14T05:20:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/250mg-ef208ad4c965131f 2026-09-14T05:19:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-viiv-s-tivicay-pd-for-newborn-hiv-patients-bc39eeceea971edb 2026-09-14T05:16:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/6fff47f596154c3c 2026-09-14T05:13:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/allan-shaw-biotech-s-real-risk-isn-t-dilution-it-s-building-a-brand-of-generic-b90057b607ebcb91 2026-09-14T05:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/noxopharm-moves-lupus-skin-therapy-toward-next-human-trial-4c0656af8b7f5c97 2026-09-14T05:04:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-10-31-508e7734f0ab565e 2026-09-14T04:55:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-best-gene-editing-stocks-for-2026-and-how-to-invest-2370cdd322149d26 2026-09-14T04:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rebuilding-food-safety-regulation-in-the-united-states-c37766891763882d 2026-09-14T04:23:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-years-on-ff6ab05ab218af7e 2026-09-14T04:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-monotherapy-demonstrates-a-statistically-significant-clinically-mean-de95279f4726a52b 2026-09-14T03:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-9d2c4846e90ee934 2026-09-14T03:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-drug-delayed-lung-cancer-progression-by-6-months-in-a-trial-85662fec9375d10a 2026-09-14T03:56:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-how-zombie-cells-fuel-inflammation-as-we-age-2a65e8d401f0c70c 2026-09-14T03:48:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-warns-us-over-alleged-espionage-targeting-ai-chip-biotech-companies-bf9f9adcacb5b3da 2026-09-14T03:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nsf-memo-implementing-trump-s-golden-age-of-science-unsettles-researchers-6c99ca378d76a029 2026-09-14T03:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/79-were-alive-eight-years-later-on-astrazeneca-s-lung-cancer-drug-versus-64-on-p-98fd92d7250b9744 2026-09-14T02:18:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-destiny-lung04-trial-shows-first-line-trastuzumab-deruxtecan-significant-547549369a0f3eab 2026-09-14T02:13:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-proposal-to-improve-access-to-medicines-for-people-with-high-blood-press-216d352b0acc20da 2026-09-14T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cullinan-taiho-showcase-6-month-survival-benefit-in-phase-3-trial-for-advanced-l-ac746721ed14d229 2026-09-14T01:44:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/popular-sweetener-byproduct-damages-dna-in-human-cells-875d3e81afbffb32 2026-09-14T01:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-pharmaceutical-r-d-infrastructure-competition-key-trends-strategies-in-a02a6e13d45ee46d 2026-09-14T01:11:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-2026-10-9-ca61e34a15073746 2026-09-14T01:09:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eastward-shift-in-the-biotech-world-why-india-and-china-could-lead-the-next-c7351acce8a9a57e 2026-09-14T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-s-new-drug-application-for-zasocitinib-receives-fda-priority-review-b3718f83bf05a0c3 2026-09-14T00:19:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-d8ea6923c50c50be 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-8f0a4cbe341f351b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-47a909258d7896e0 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-e03dfe4679ebf435 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-new-drug-application-filing-accepted-for-review-in-china-for-stn1012700-a-f5d677282047d1cf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-tumor-dna-guided-de-escalation-or-escalation-of-adjuvant-therapy-in-33260be14e789b13 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-valine-metabolism-and-ferroptosis-to-overcome-chemoresistance-in-pdac-8977c572ca4c3019 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-multi-omics-reveals-itgb2-drives-the-mesenchymal-transition-in-gliobl-7c3094583740f863 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-active-tca-cycle-state-defines-a-high-risk-acute-lymphoblastic-leukemia-subty-947c47fd1ee80584 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/simultaneous-speech-and-gesture-decoding-for-multimodal-communication-in-paralys-918f9abd51cba68b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/overlapping-representations-in-the-ventral-hippocampus-support-rapid-fear-memory-d3ac9eddc90bfec9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/de-novo-mutations-bridge-parental-reproductive-factors-and-offspring-health-8be568c76c5a162d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-evidence-for-conversational-medical-ai-is-hard-but-non-negotiable-d6d1ad6ff34cbc4d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-the-global-health-system-for-a-new-international-order-d3f05387a29b0c9f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-engineered-nanopore-identifies-saccharides-amino-acids-peptides-and-ribonucle-8d5782171936be08 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/encoded-and-non-genetic-protein-variants-expand-human-functional-proteome-afeeb34d6d45b510 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daily-briefing-how-this-year-s-super-el-nino-is-different-ab49928fb39b415d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-roots-of-astrology-the-mysterious-nature-of-time-and-more-books-in-brief-a40cac2df779716b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multifunctional-brain-implant-translates-speech-and-gestures-in-real-time-98ef90b9e12516c9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pet-trade-puts-reptiles-and-amphibians-at-risk-close-legal-gaps-now-c833b4033d5e9b4b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fraud-sealed-the-fate-of-controversial-zoologist-paul-kammerer-100-years-on-his-a0f2a6966b73a820 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-is-climate-change-affecting-conifers-and-their-ability-to-sequester-carbon-5d073bedc0724911 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-philanthropy-is-rising-in-brazil-upending-a-long-tradition-4932ddfb137d34bb 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-universities-are-on-the-brink-what-is-their-greatest-source-of-stress-692c73192e09257c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-irvine-labs-inc-1350cffdd1f6ab38 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-cambrex-high-point-inc-008e3b2bc6e1d789 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-dce179460387c8ae 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcing-the-intent-to-award-a-single-source-supplement-for-expanding-outreach-f9898d8cf2a86252 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitation-for-nominations-to-serve-on-the-advisory-council-to-support-grandpa-6ebc6e265a932df5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitation-for-nominations-to-serve-on-the-family-caregiving-advisory-council-31910611e58db2c4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-8f8b60381133a48a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/office-of-the-national-coordinator-for-health-information-technology-health-info-b544a4acb9b8b8f6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-b02f31e37dc3ec91 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-nih-electronic-application-system-for-1920dece3f62af8f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/draft-nih-biosafety-policy-for-research-involving-biohazards-29b2690afa1577d6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-forsta-hur-barncancer-uppstar-och-utvecklas-a83d8f96f13a771f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-metod-testad-mot-bakteriellt-toxin-i-hjarnan-2e3264bcd07ffd28 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metabolisk-sarbarhet-kan-paverka-hjartats-utveckling-3b11b9ad02177fe0 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/luana-naia-ny-forskargruppsledare-vid-nvs-76120bf4505b105e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kan-fargen-halla-sig-i-skinnet-65da493c1ae09835 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/camilla-lagerberg-ny-biobanksansvarig-vid-ki-7953c9f664813263 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tips-for-managing-picky-eaters-73025e3e46b751cc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-begins-offering-appointment-only-flu-vaccinations-5c438e2467aed99f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/smart-pharmaceutical-packaging-market-forecast-report-featuring-segment-analysis-55a8d6ef43850c1d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-advances-of-the-year-in-autologous-cellular-therapy-in-melanoma-and-solid-tu-1f92b0ebe41572ce 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implications-of-potential-us-fda-approval-of-psychedelics-or-psychedelic-adjacen-8b3f3520f48b0627 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-associations-between-glp-1-receptor-agonists-and-polyendocrine-metabol-279694c5d785fc3a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-celecoxib-combined-with-jintiange-capsules-for-the-treatm-e71b3692cb8b1294 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lipoprotein-a-in-japan-an-expert-consensus-statement-9e5280d6ea38688c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/encarcelando-eslabones-descartables-microtrafico-en-mujeres-bolivianas-y-su-vinc-78099e7bb631f301 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endoscopic-retrograde-cholangiopancreatography-versus-endoscopic-ultrasound-guid-06fe4129655d1ee6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-outcome-of-sac-ligation-versus-no-sac-ligation-in-pediatric-patien-532a18f6cf6f4daa 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-trial-of-periumbilical-incision-versus-intraumbilical-incision-in-em-3b7d7e84584d0075 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/penicillin-a-journey-from-a-magic-bullet-to-a-resistant-drug-9f783258c6f90946 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-community-alongside-clinical-practice-community-music-therapy-as-soci-e648dcea05dfc2dc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tuberculosis-resistente-a-farmacos-y-factores-asociados-en-santa-fe-2021-2024-c10ac6bde98c4961 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-silico-adme-toxicity-profiling-of-3-4-dithia-1-azabicyclo-3-2-0-heptan-7-one-caf23f7a863538aa 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genicular-artery-embolization-in-primary-and-secondary-knee-osteoarthritis-clini-9bb5724954bb9262 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-tep-and-lichtenstein-repair-in-bilateral-inguinal-hernia-su-75f20d92150782da 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-incidental-colorectal-fdg-avid-lesions-on-oncologic-18f-ed6e93d4e1e114be 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-soft-tissue-mobilization-and-kinesio-taping-on-sportive-performanc-99d998bcb0793088 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unveiling-ai-augmented-periodontal-decision-making-a-comparative-clinical-evalua-afd3857e16b239eb 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/utilization-of-long-acting-injectable-antipsychotics-and-clozapine-in-coordinate-b1a839103df3000d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-translational-nephrology-in-global-primary-care-bridging-innovation-pre-7f9c25f39ef7100a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-fine-needle-aspiration-i-vs-i-fine-needle-biopsy-in-so-dbf723366d924d81 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rural-urban-differences-in-breast-cancer-epidemiology-nutritional-status-and-cli-bbc480129a89ee6a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quasi-experimental-trial-examining-the-effectiveness-of-driver-training-modules-b9eb6d77db7b1dab 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-translation-of-fisetin-for-age-related-diseases-current-evidence-and-fu-3668d87d5ee7a0ca 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asthma-and-sinonasal-diseases-shared-clinical-comorbidities-inflammatory-pathway-afac4b7bf1e62340 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preoperative-frailty-inflammation-phenotypes-and-early-functional-and-patient-re-7f649c25063dbf2a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prenatal-and-postnatal-identification-of-phelan-mcdermid-syndrome-in-a-tertiary-1992aa669c4b0d5e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-differential-posterior-tibial-slope-on-clinical-outcomes-following-42a7ccaaa95fd46c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paired-urinary-cytology-and-targeted-fgfr3-s249c-r248c-mutation-detection-in-uri-4f195e94a047b77e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-granzyme-b-in-parkinson-s-disease-a-case-control-study-of-diagnostic-assoc-915548369384ad65 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-ankaferd-hemostat-mouthwash-for-high-grade-oral-mucositis-d-dd6bbd11a2889475 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/responsible-clinical-ai-in-dentistry-trust-professional-autonomy-and-perceptions-bf5bf089fe84f1c4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-global-burden-of-eustachian-tube-dysfunction-in-older-patients-pathophysiolo-458aaa33a1cfbbdc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-advances-in-spinal-muscular-atrophy-a-review-of-clinical-safety-and-d99e25370b464471 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-minimum-discard-volume-for-central-venous-catheter-sampling-valida-face44472c6caf57 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-colorectal-cancer-multidisciplinary-decision-making-c-5b2c364273f7c68c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/piwil4-from-biological-characteristics-to-disease-pathogenesis-and-clinical-appl-fe625d656dadd63f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secretory-carrier-membrane-protein-3-modulates-nuclear-erk1-2-signaling-and-drug-f0a176772406d686 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicinal-mushrooms-and-type-2-diabetes-mechanistic-insights-translational-evide-c67fcbde1cdfbd95 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-effects-of-probiotic-supplementations-on-metabolic-syndrome-a-syste-3ee1432f47c34b56 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/controlled-low-central-venous-pressure-after-cardiopulmonary-bypass-reduces-acut-377e84517695fe80 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-microbe-interactions-in-pediatric-ulcerative-colitis-clinical-features-pa-a9a0449f50bfee25 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-checkpoint-inhibitor-associated-arrhythmias-clinical-challenges-artificia-ae5d84fef5706750 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/porous-silicon-nanoparticles-in-drug-delivery-regenerative-medicine-and-biosensi-1227a29e48efd94e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/closed-loop-non-invasive-ventilation-in-critical-care-current-evidence-and-clini-2f6f8236ab093dda 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unraveling-the-mystery-of-status-epilepticus-a-retrospective-study-at-a-tertiary-a9048ab8cd680ff1 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-biofertigation-for-enhancing-growth-and-yield-of-blackgram-vigna-m-ac7b85d563f235a6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-phytochemical-screening-and-in-vitro-anthelmintic-evaluation-of-etha-ce97e601cabab040 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modified-tibial-plateau-leveling-osteotomy-using-a-precontoured-plate-achieves-s-73e5b5184a8265e7 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-computational-study-of-some-cancer-causing-s100-proteins-interacting-with-a-li-03ed20d4c40a4d43 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-care-for-patients-with-leprosy-impact-on-treatment-adherence-and-008e2fd16c1d0c1c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-external-validation-of-a-machine-learning-based-clinical-predict-4d88db5e80c48cba 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-of-pretreatment-neutrophil-to-lymphocyte-ratio-and-thyroid-related-dbbd59bacc22f2b8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-reminiscence-therapy-on-the-resilience-and-satisfaction-with-care-d442db71ae84ac7c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beta-lactam-dose-optimization-using-therapeutic-drug-monitoring-in-pediatric-pat-e3ca0a48c61a6b6b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparation-of-transdermal-patch-as-a-drug-delivery-system-for-treatment-of-urin-b682b2e2a273a1b5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interference-by-saline-based-reconstitution-of-lyophilized-quality-control-plasm-4b8636f570f38727 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-celecoxib-combined-with-jintiange-capsules-for-the-treatm-f8b897f6293fe297 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-resting-and-dobutamine-stress-myocardial-work-in-cirrho-2c6fc0ec97666692 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-therapist-adoption-of-evidence-based-practices-with-the-loci-strategy-49a6ac97edcbf0df 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-the-role-experiences-of-clinical-nurse-educators-in-the-process-of-i-5723d793e7d5ea7c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-survey-on-the-current-clinical-use-and-perceptions-of-warm-needle-acupuncture-ecb43b6a39884080 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-safety-of-curcumin-for-the-prevention-and-treatment-of-rad-3adc6b63e3e0b97b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-invasive-biofeedback-assisted-vs-conventional-pelvic-floor-muscle-training-c-c024152c1924ea13 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-implementation-changes-in-the-procurement-volume-and-patterns-of-oral-hypog-12f2a4df784c8026 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-infective-endocarditis-in-children-a-single-center-o-155b307787d443f8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-clinical-value-of-mir-122-expression-and-genetic-locus-variants-in-ped-2c58e79476f42db4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-prognostic-model-integrating-systemic-inflammation-and-clinical-features-for-o-4ba9b87bf15bafe3 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preventability-of-adverse-drug-reactions-to-anticancer-drugs-insights-from-the-d-6e0304153ab4cab5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-intraoperative-systolic-blood-pressure-variability-and-clinical-o-ba5dfdd788dcf654 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-drug-delivery-systems-for-osteoarthritis-therapy-exosomes-microparti-e0b306b586959ea6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paired-oral-clinical-specimens-reveal-the-underlying-ecology-supporting-the-emer-452251b0fbaa9af4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/library-strategies-differentially-shape-microbial-functional-and-host-signals-in-ed7d88ee8c97421b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/palmar-plantar-ligament-injuries-in-five-horses-clinical-findings-comparative-di-5236f722da22c599 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pseudoangiomatous-stromal-hyperplasia-of-the-breast-clinical-radiologic-and-hist-ab64f7b05784a45f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-pharmacy-professionals-workplace-satisfaction-in-a-conflict-affect-b9bccd32f45054ac 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-future-of-pharmaceuticals-strategic-foresight-in-an-era-of-uncertainty-aa902f719a466343 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-progress-in-gene-therapy-for-rpgr-associated-x-linked-retinitis-pigment-54539ea3fc0cc69f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogen-bonded-poly-vinyl-alcohol-tannic-acid-quercetin-hydrogels-for-localized-ac652fd7b3c4269d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-in-vitro-i-assessments-for-pharmacokinetic-drug-drug-interaction-potential-of-cf08e40435812d90 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogen-rich-water-ingestion-alleviates-downhill-running-induced-muscle-sorenes-d0207f0a4e64aea6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nat10-as-a-context-dependent-epitranscriptomic-hub-governing-cancer-drug-resista-22f80dfb63466a0b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-vascular-and-cardiac-parameters-on-quality-of-life-in-patients-undergo-a52b60a8304f8b42 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/old-drug-with-new-application-spironolactone-suppresses-panx-1-mediated-ca2-infl-01c4d8120aeb176c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/craniofacial-morphology-and-dental-age-assessment-in-pediatric-craniosynostosis-4c9a55058c7e2458 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-burdens-of-long-term-cadaver-pool-storage-solutions-a-screening-cr-4d8320b83900e71e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practical-computational-exploration-of-chemical-reaction-space-assessing-the-che-e45d4b674d9e7dbf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neonatal-ventilation-training-using-a-low-cost-high-fidelity-simulator-in-a-low-352ce6c5484f86fe 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819110-radicle-healthtm-vip-a-study-assessing-the-impact-of-health-and-well-306e35e216d7a229 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818395-spatial-multi-omics-of-perineural-invasion-microenvironment-and-prog-9eae5da708518537 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818174-graded-motor-imagery-effects-on-body-perception-disturbance-in-compl-6fa37c136a3eadb5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07817186-clinical-trial-of-a-mek-inhibitor-for-rasopathy-associated-severe-in-cfc658dba67c417c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07817004-qlm2010-comparative-pharmacokinetic-study-with-2-minute-intravenous-90a7bd456c2fdff5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816731-effect-of-face-to-face-and-virtual-reality-based-salutogenesis-nursi-b72760fa4d356199 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816666-torvutatug-samrotecan-with-or-without-bevacizumab-as-maintenance-tre-ef10e449d172cc7f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07815678-first-in-human-study-of-the-safety-tolerability-pharmacokinetics-and-7bfba9cc2885eb22 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810478-criteria-based-rehabilitation-after-tibial-fracture-fixation-a-rando-a829f93786110c1b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07739459-study-of-zanubrutinib-in-older-patients-with-previously-untreated-ch-8e97594244b216f5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07673913-relationship-of-peripheral-inflammatory-and-neuroprotective-biomarke-2ca4185331048bcb 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07554339-a-clinical-trial-of-calderasib-mk-1084-and-durvalumab-in-people-with-8682652bb67ca21f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07516184-explore-the-diagnostic-value-of-bronchodilation-test-with-portable-o-5c13347c1faf4c64 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07513389-omission-of-postoperative-radiation-in-hpv-associated-oropharyngeal-54433fa6534bad2b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07465757-a-study-of-alisertib-and-paclitaxel-in-patients-with-small-cell-lung-dde461375ff0295b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07451899-tb-type-and-spirometry-result-vs-functional-capacity-based-on-6mwt-i-21d29ab24081d675 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07218146-a-study-of-zl-1310-versus-investigator-s-choice-of-therapy-in-partic-767ee1cfeea38d53 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07098351-efficacy-and-safety-of-nalfurafine-hydrochloride-odt-for-moderate-to-095639059132fe18 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991738-177lu-dota-eb-tate-in-adult-patients-with-metastatic-radioactive-iod-8bb88397e09523fd 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06899308-health-surveillance-at-constructor-university-bremen-cub-5de96b94d7255aa9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06860698-the-impact-of-chronic-e-cigarette-usage-on-microvascular-health-fd1ed5abb1124fed 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06820463-a-study-to-evaluate-the-adverse-events-and-efficacy-of-intravenous-i-8e023f916ad246b4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06797661-insights-into-the-pathophysiology-of-neurovascular-uncoupling-in-pat-88c52fa05421580c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06794125-an-evaluation-of-dose-escalation-for-intrathoracic-tumours-03fc06b394cbb28a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06789198-peptide-vaccine-for-fibrolamellar-hepatocellular-carcinoma-patients-73706391bfa20375 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06595940-genetic-analysis-of-uncommon-disease-presentations-in-non-us-populat-9a7defcdd77feca2 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06590051-amg-335-expanded-access-program-for-igg4-related-disease-c8325929e8dbbc09 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06549153-act-together-acting-on-cancer-testing-together-a08de136fdf3c7c8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06282575-efficacy-and-safety-of-zanidatamab-with-standard-of-care-therapy-aga-f51095141a5f7f25 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06263283-impact-of-an-educational-physiotherapy-yoga-intervention-on-perceive-9a1f907fc02817ea 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06065748-a-study-to-evaluate-efficacy-and-safety-of-giredestrant-compared-wit-0ef2bd2d0a1567bf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05827081-phase-iiib-study-of-ribociclib-et-in-early-breast-cancer-af4028810169a04c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05642195-evaluation-of-a-cancer-lysate-vaccine-and-montanide-registered-trade-6c3881e00781f72d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05482516-evaluating-novel-therapies-in-ctdna-positive-gi-cancers-6ccbf36dce5d5e63 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05172245-testing-the-addition-of-ipatasertib-to-usual-chemotherapy-and-radiat-f6b6c429408def1b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05041387-data-collection-of-standard-care-of-patients-in-the-emg-section-ac1d0af4063522b8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04751409-evaluating-the-impact-of-limited-compared-with-intense-post-operativ-3914dd6bd3bf878c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04708067-hypofractionated-radiation-therapy-and-bintrafusp-alfa-for-the-treat-cbd312bb31198efe 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04543617-a-study-of-atezolizumab-with-or-without-tiragolumab-in-participants-78dab5b9bab22eb7 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04449549-rapid-analysis-and-response-evaluation-of-combination-anti-neoplasti-ff3252eaf85eba3c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04221750-diet-and-exercise-plus-metformin-to-treat-frailty-in-obese-seniors-5d3925a3863eaf7b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04115631-a-comparison-of-three-chemotherapy-regimens-for-the-treatment-of-pat-12d28c00c5a80ada 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04021329-efficacy-of-eye-movement-desensitization-reprocessing-versus-cogniti-3e36390b02b80510 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03683433-enasidenib-and-azacitidine-in-treating-patients-with-recurrent-or-re-cbfde361bf4fd7fc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03533582-cisplatin-and-combination-chemotherapy-in-treating-children-and-youn-b835c20426c4e184 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03214562-venetoclax-with-combination-chemotherapy-in-treating-patients-with-n-1046bc1f29df907e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03137511-optimizing-access-to-care-through-new-technologies-a-randomized-stud-4da9fa163d38b237 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02698579-long-term-follow-up-of-participants-with-cerebral-adrenoleukodystrop-d760eb80889e1868 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01660984-natural-history-study-of-children-and-adults-with-medullary-thyroid-5dc6ce49fdf8cca4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01630278-early-ibuprofen-treatment-of-patent-ductus-arteriosus-pda-in-prematu-9425d0c4c406003d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01386034-effects-of-oral-citrulline-on-protein-metabolism-in-patients-with-in-2d6bd6a6fb3bf396 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01061255-stress-and-clinical-reasoning-in-medical-students-c8bea47dc082710b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00841724-study-of-a-reduced-toxicity-submyeloablative-conditioning-regimen-pr-a06f1679c838c0a1 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00791635-longitudinal-evaluation-of-women-undergoing-pelvic-surgery-for-the-t-44d99c489e3f4c7a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-second-drug-hits-fda-safety-hurdle-78904628f6a4b1e0 2026-09-13T23:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-ge-healthcare-to-buy-sofie-biosciences-for-1-billion-as-part-of-pharmaceu-76ac7840b032d4ac 2026-09-13T23:44:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/kipspharma-receives-ind-approval-for-domestic-phase-2-trial-of-idetrexed-1e64d7af2db82ac9 2026-09-13T23:36:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-4f45197febb26aa1 2026-09-13T23:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-prepares-frontline-fda-bid-for-jideytro-its-first-lung-cancer-drug-0f6add197193563c 2026-09-13T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-dispersants-market-forecast-to-2035-biologics-and-cell-therapy-dr-20b76c50b6aa2cee 2026-09-13T22:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-us-medicare-pricing-policies-could-reshape-global-pharmaceutical-markets-796dc218c7715e5a 2026-09-13T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-stock-faces-pressure-after-rival-s-clinical-trial-miss-2ebdc81c4c996a43 2026-09-13T22:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gas-preheating-modules-market-forecast-to-2035-growth-driven-by-semiconductor-an-b55c48aa66aef3e6 2026-09-13T21:26:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-advances-medical-cannabis-as-neocannbio-builds-gmp-capacity-chosunbi-24a6a75a7ed952d4 2026-09-13T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-journey-from-ebola-to-innovative-treatments-8194ac8c0bba5c74 2026-09-13T20:58:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/emyria-to-speak-at-us-fda-hearing-3c0cbf4041772dcb 2026-09-13T20:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/servier-partnering-day-connecting-pharma-biotech-and-academia-for-new-opportunit-e9b0088d23d43ad2 2026-09-13T20:54:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncy-stock-on-track-for-worst-day-in-about-a-year-ahead-of-fda-decision-on-lead-781ead4101837786 2026-09-13T20:37:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-kerala-pappadam-rules-to-old-monk-scrutiny-when-routine-food-and-drug-enfor-1a02121b9e57e7f2 2026-09-13T20:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-snaps-2-day-slide-sellas-sls009-aml-trial-spotlights-big-pharma-drug-c-f36c0d0b6d235967 2026-09-13T20:03:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-presents-positive-registrational-data-to-potentially-expand-jideytro-zidesam-61324be0e8c113f6 2026-09-13T19:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-falls-on-2b-notes-deal-is-the-cancer-rally-still-intact-4f0abf3080032390 2026-09-13T17:52:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-zhejiang-chengyi-pharmaceutical-co-ltd-class-a-stocks-a4002021b818d1df 2026-09-13T17:38:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-breakthrough-cancer-vaccine-fueled-a-biotech-rally-can-it-last-16c0e73db8d97a9a 2026-09-13T17:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-stocks-to-watch-today-september-13th-ac86db9ba49d8ae3 2026-09-13T16:04:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptides-approved-so-far-have-limited-human-research-748b4e7ba137702b 2026-09-13T15:52:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/makinde-others-to-grace-psn-oyo-2026-world-pharmacists-day-f74cb2bf371b0c73 2026-09-13T15:32:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-sponsor-s-playbook-for-irt-success-cc08578ef00a6ee4 2026-09-13T15:15:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/dbvt-slides-as-dbv-technologies-leads-european-biotech-declines-bfb64ba5124bdf18 2026-09-13T15:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-trade-this-2-billion-biotech-name-moving-quickly-toward-profit-e72df0c44deb6bd8 2026-09-13T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-small-cap-biotechs-with-binary-catalysts-on-the-calendar-451f0e34f912ed8e 2026-09-13T14:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-small-cap-biotechs-with-binary-catalysts-on-the-calendar-3c11057fc1f82d23 2026-09-13T14:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-drugs-from-other-states-emerge-as-new-challenge-for-punjab-police-964229af63a04d03 2026-09-13T13:58:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-new-layer-of-alzheimer-s-hidden-in-the-genome-35b0fdbf0dcfcd9d 2026-09-13T13:56:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/most-men-don-t-know-dairy-is-linked-to-prostate-cancer-risk-825face74526a00d 2026-09-13T12:58:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/yesterday-when-i-was-young-how-grief-and-music-motivate-this-hong-kong-biotech-s-6bbb76fd500ed8c5 2026-09-13T12:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/drinking-water-in-pet-bottles-found-safe-fda-402bb54191a107af 2026-09-13T12:33:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-stock-stabilizes-after-trial-setbacks-as-investor-pushes-for-board-shak-91c49459cb9bde0d 2026-09-13T12:19:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/roivant-sciences-diverse-exposure-to-biotech-niches-through-vants-nasdaq-roiv-f755b46573c262a0 2026-09-13T11:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/punjab-sees-shift-in-drug-trade-heroin-availability-falls-pharmaceutical-narcoti-3c356b6a4ec030fc 2026-09-13T11:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heroin-supply-falls-in-punjab-but-pharma-drugs-from-other-states-emerge-as-new-c-553dd4232e825186 2026-09-13T11:13:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-hebei-changshan-biochemical-pharmaceutical-co-ltd-class-a-stoc-12d05f5761881b7d 2026-09-13T11:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-uncovers-hidden-ozempic-side-effects-across-400-000-reddit-posts-4761f9e77bac6a9e 2026-09-13T10:46:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-patent-office-issues-draft-guidelines-for-pharma-biotech-patents-f5ea25ff845c0d58 2026-09-13T10:20:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/kardigan-funded-precision-cardiology-offers-more-than-pipeline-diversification-903862474345a45e 2026-09-13T10:10:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/aan-ahs-issue-updated-guideline-on-migraine-prevention-atogepant-meets-end-point-fba9ebb04f21030b 2026-09-13T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientist-challenges-pharmaceutical-ceo-7d668b086603b6da 2026-09-13T09:34:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mirum-s-azure-3-trial-a-new-switch-strategy-in-chronic-hepatitis-d-7e2f82ccd93e8fa1 2026-09-13T09:17:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-waiting-times-latest-updates-and-analysis-bd327724e0706e0a 2026-09-13T09:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-and-civic-groups-in-south-korea-rally-to-block-telemedicine-drug-del-b3f335563b1d4740 2026-09-13T08:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kush-choksi-promoted-to-assistant-vice-president-business-development-at-strides-67d859a68cdf70fc 2026-09-13T08:25:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/russians-attack-ukraine-s-second-largest-pharmaceutical-warehouse-twice-e64594d4abfd7904 2026-09-13T08:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merali-family-acquires-stake-in-sh330-million-mombasa-glass-plant-534ff22c2cb25d15 2026-09-13T08:06:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-state-teachers-retirement-system-grows-holdings-in-teva-pharmaceutica-401670e366181271 2026-09-13T08:06:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-patent-office-releases-draft-pharma-and-biotech-patent-rules-745c2dc8449c8b47 2026-09-13T08:04:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ris-rez-reduced-risk-of-death-by-54-versus-topotecan-in-patients-with-relapsed-s-bc1325534320d150 2026-09-13T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcaz-remedica-medicine-recall-zimbabwe-for-nifedipine-levodopa-4a21d23560bf1cee 2026-09-13T07:29:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitapivat-just-rewrote-the-treatment-floor-for-transfusion-dependent-thalassaemi-0e1aeb228fea5f5f 2026-09-13T07:28:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-patent-office-proposes-new-guidelines-for-pharma-patent-examination-5171aedfc3e70ab9 2026-09-13T07:21:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/tam-peli-meets-primary-endpoint-for-relapsed-small-cell-lung-cancer-in-phase-iii-ac7af87a08f589ad 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/iza-bren-2-5-mg-kg-dose-advances-to-phase-3-in-egfr-mutated-nsclc-70789e99d842e835 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-exits-laa-closure-market-sells-laminar-program-to-jaguar-laa-77731cf65f918dd3 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurobindo-s-curateq-biologics-reports-positive-phase-3-results-for-omalizumab-bi-65c6bb10b421292e 2026-09-13T06:07:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ntla-stock-surges-35-overnight-retail-mood-peaks-ahead-of-first-ever-phase-3-rea-d5beb93535a18e5e 2026-09-13T05:49:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/chilling-warning-or-overreaction-ai-bioweapons-report-divides-experts-3a4cfde44468df42 2026-09-13T04:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supreme-court-asked-to-restore-access-to-mail-order-abortion-pill-mifepristone-20d9cb41edbc928e 2026-09-13T04:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-drug-combination-falls-short-in-first-line-pd-l1-high-metastatic-lung-c-355a95d6d905ce35 2026-09-13T04:02:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/centric-compounding-issues-nationwide-recall-of-glutathione-myer-s-cocktail-and-b5a72d52260ba24e 2026-09-13T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/confined-simulations-offer-a-new-route-to-predict-nucleation-82eaeca0ca42a42b 2026-09-13T03:51:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-hidden-compound-in-healthy-foods-may-worsen-ibd-13ad654b444126b6 2026-09-13T02:47:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ozempic-and-wegovy-may-raise-hair-loss-risk-in-some-men-53d4ac29810e0090 2026-09-13T02:18:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/holiferm-and-organica-uk-combine-to-build-integrated-biotech-and-sustainable-pro-326ddd6adcb0a06e 2026-09-13T02:17:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-summit-s-ivonescimab-tops-keytruda-in-lung-cancer-survival-with-strong-dat-63d1edeae3bf3d46 2026-09-13T01:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-gilead-s-failed-trodelvy-lung-cancer-trial-shows-better-china-results-76c37bd818cc89c6 2026-09-13T01:44:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-a-hidden-switch-that-shuts-down-inflammation-3d0c361bd8fd4e00 2026-09-13T01:44:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/bhushan-malpure-elevated-to-head-of-marketing-at-cipla-9e97a17d55f1f388 2026-09-13T01:26:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyester-thermal-ribbon-material-market-forecast-to-2035-driven-by-coding-and-m-423a025c3eff05f6 2026-09-13T00:41:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-hits-over-3-year-high-as-aml-drug-trial-nears-final-readout-wall-stree-d690b1c596b74875 2026-09-13T00:37:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-cancer-drug-cut-death-risk-54-in-a-phase-iii-trial-aa806bf235967344 2026-09-13T00:13:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-collaborator-medilink-announces-phase-iii-data-for-tam-peli-showing-sign-59cd66eaa83f33ab 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multimodal-murmuration-for-immunotherapy-979c93f560e95e19 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-her2-expression-and-erbb2-alterations-in-bladder-cancer-4ea80dc605ea0fc0 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/linezolid-in-the-era-of-bedaquiline-pretomanid-linezolid-based-regimens-an-indis-8e924ce3b153dea5 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-tolerability-of-linezolid-to-treat-tuberculosis-a-systematic-review-a-fb2e66d13330fbbb 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implications-of-potential-us-fda-approval-of-psychedelics-or-psychedelic-adjacen-22a00289bf033253 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-and-safety-interactions-between-aildenafil-and-clarithromycin-ci-9c218951a83f2a36 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-her2-expression-and-erbb2-alterations-in-bladder-cancer-a725c901a29fc8a8 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transfascial-paraspinal-versus-conventional-open-posterior-pedicle-screw-fixatio-702e3f0c54fd95bc 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-fever-hides-fire-a-systematic-review-of-clinical-and-digital-approaches-to-3b1675982556c63d 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-clinical-biological-and-echocardiographic-factors-independently-assoc-d9399d45b2a33f73 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-interpretable-machine-learning-technique-for-chronic-kidney-disease-diagnosis-a36eb0bcde8fec07 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hemodynamic-assessment-of-different-septic-shock-resuscitation-strategies-a-comp-2e608c74e044dc35 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-daily-versus-thrice-weekly-antituberculosis-therapy-for-drug-susceptible-0c5ecbecd8d647ea 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotypic-biofilm-formation-and-detection-of-biofilm-associated-genes-in-multid-36922277a1ca5ce2 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-dupilumab-therapy-in-atopic-dermatitis-and-prurigo-nodularis-clinical-3093d0df68a96ae7 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/directions-for-improving-drug-provision-for-outpatients-with-diabetes-mellitus-c70325f08c56201e 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-the-informativeness-of-the-snot-22-questionnaire-in-patients-with-4e9dcdbe265cd94a 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/altered-pharmacokinetics-and-drug-dosing-in-obese-patients-a-traditional-review-e229aee037800092 2026-09-13T00:00:00.000Z weekly 0.7